{
  "meta": {
    "title": "Late_Night_Pyq_Inicet_Mixed_Bag-25",
    "url": "https://brainandscalpel.vercel.app/late-night-pyq-inicet-mixed-bag-25-aabd941d.html",
    "scrapedAt": "2025-11-29T18:11:28.771Z"
  },
  "questions": [
    {
      "id": 74908,
      "choices": [
        {
          "id": 298529,
          "text": "<p><span style=\"font-size:16px;\">Nuclear pattern; SLE</span></p>"
        },
        {
          "id": 298530,
          "text": "<p><span style=\"font-size:16px;\">Homogeneous pattern; SLE</span></p>"
        },
        {
          "id": 298531,
          "text": "<p><span style=\"font-size:16px;\">Speckled pattern; Systemic sclerosis</span></p>"
        },
        {
          "id": 298532,
          "text": "<p><span style=\"font-size:16px;\">Anti-centromere pattern; Systemic sclerosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A patient presented with recurrent Raynaud’s phenomenon. She also complained of thickening of skin in the hands and difficulty in swallowing. What is the diagnosis and immunofluorescence pattern shown? (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xOrfzxr.png\" width=\"383\" height=\"381\"></span></p>",
      "unique_key": "Q5245863",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390865,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Anti-centromere pattern; Systemic sclerosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The combination of Raynaud's phenomenon, skin thickening limited to hands (acral areas), and difficulty swallowing points to <strong>limited systemic sclerosis</strong> (formerly called CREST syndrome). The immunofluorescence image shows a characteristic <strong>centromeric pattern</strong> with discrete speckles corresponding to centromeres in dividing cells. Anti-centromere antibodies are specifically associated with <strong>limited systemic sclerosis</strong>, making this pattern diagnostic in this clinical context.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Nuclear pattern; SLE:</strong> Incorrect. The pattern shown is centromeric, not nuclear.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Homogeneous pattern; SLE</strong>: Incorrect. Homogeneous patterns are produced by anti-histone and anti-dsDNA antibodies, seen in SLE or drug-induced lupus.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Speckled pattern; Systemic sclerosis:</strong> Incorrect. While speckled patterns can be seen in systemic sclerosis (particularly with anti-Scl-70 antibodies in diffuse disease), the image shows a <strong>centromeric</strong> pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Anti-centromere antibodies producing a centromeric immunofluorescence pattern are specifically associated with <strong>limited systemic sclerosis</strong>, particularly when presenting with Raynaud's phenomenon and acral skin thickening.</span></p>",
      "correct_choice_id": 298532,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74908/INI-CET_NOV_2024_Medicine_Q_-_33.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74908/INI-CET_NOV_2024_Medicine_Q_-_33.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24677,
      "choices": [
        {
          "id": 98669,
          "text": "<p><span style=\"font-size:12.0pt;\">3-2-4-6-7-5-1</span></p>"
        },
        {
          "id": 98670,
          "text": "<p><span style=\"font-size:12.0pt;\">2-3-4-6-7-5-1</span></p>"
        },
        {
          "id": 98671,
          "text": "<p><span style=\"font-size:12.0pt;\">2-3-6-4-5-7-1</span></p>"
        },
        {
          "id": 98672,
          "text": "<p><span style=\"font-size:12.0pt;\">3-2-6-4-7-5-1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Organize the subsequent structures in the auditory pathway, beginning from the receptors and moving towards the cortex: (</span>INICET May 2023)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Auditory Cortex</span></li><li><span style=\"font-size:12.0pt;\">Spiral ganglion</span></li><li><span style=\"font-size:12.0pt;\">Cochlear Nucleus</span></li><li><span style=\"font-size:12.0pt;\">Lateral leminiscus</span></li><li><span style=\"font-size:12.0pt;\">Inferior colliculus</span></li><li><span style=\"font-size:12.0pt;\">Olivary complex</span></li><li><span style=\"font-size:12.0pt;\">Medial geniculate body</span></li></ol><p>&nbsp;</p>",
      "unique_key": "Q2911846",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390866,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 2-3-6-4-5-7-1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct sequence of structures in the auditory pathway, beginning from the receptors (cochlea) and moving towards the auditory cortex, is as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Spiral ganglion</strong>: The auditory nerve fibers originate here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Cochlear Nucleus</strong>: The auditory nerve fibers synapse in the cochlear nuclei located in the brainstem.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>6. Olivary complex</strong>: After the cochlear nucleus, the pathway proceeds to the superior olivary complex.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Lateral lemniscus</strong>: From the superior olivary complex, the auditory signals travel via the lateral lemniscus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>5. Inferior colliculus</strong>: The lateral lemniscus projects to the inferior colliculus in the midbrain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>7. Medial geniculate body</strong>: The signals are then relayed to the medial geniculate body of the thalamus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Auditory Cortex</strong>: Finally, the signals reach the auditory cortex (Area 41) in the temporal lobe for processing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/inicet-may-2023-ent.jpg\" alt=\"\" width=\"700\" height=\"736\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>AUDITORY PATHWAY</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">E – Eighth nerve</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">C – Cochlear nucleus</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">O – Olivary complex (superior)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">L – Lateral lemniscus</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">I – Inferior colliculus</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">M – Medial geniculate body</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A – Auditory cortex</span></p>",
      "correct_choice_id": 98671,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7044,
      "choices": [
        {
          "id": 28144,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoniazid</span></span></span></p>"
        },
        {
          "id": 28145,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifapentin</span></span></span></p>"
        },
        {
          "id": 28146,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thioacetazone</span></span></span></p>"
        },
        {
          "id": 28147,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kanamycin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following anti-tubercular drug is not bactericidal? (</span></span>INICET May 2020)</p>",
      "unique_key": "Q3921200",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390867,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Thioacetazone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thioacetazone is a bacteriostatic anti-tubercular drug. Bacteriostatic drugs inhibit the growth and replication of bacteria, rather than killing them outright. Thioacetazone is less commonly used nowadays due to its side effects and the availability of more effective treatments.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Isoniazid:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Isoniazid is a bactericidal drug against actively dividing Mycobacterium tuberculosis bacteria. It works by inhibiting the synthesis of mycolic acid, a critical component of the bacterial cell wall.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Rifapentin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Rifapentin is a bactericidal antibiotic and is a derivative of rifampicin. It works by inhibiting bacterial RNA synthesis and is used primarily in the treatment of tuberculosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Kanamycin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Kanamycin is an aminoglycoside antibiotic and is bactericidal. It works by inhibiting bacterial protein synthesis. It is used as a second-line drug for the treatment of multidrug-resistant tuberculosis (MDR-TB).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thioacetazone is a bacteriostatic anti-tubercular drug, which means it inhibits bacterial growth rather than killing the bacteria outright. In contrast, isoniazid, rifapentin, and kanamycin are all bactericidal drugs used in the treatment of tuberculosis.</span></span></span></p>",
      "correct_choice_id": 28146,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10220,
      "choices": [
        {
          "id": 40846,
          "text": "<p><span style=\"font-size:12pt;\">Borderline Tuberculoid leprosy</span></p>"
        },
        {
          "id": 40847,
          "text": "<p><span style=\"font-size:12pt;\">Lepromatous leprosy</span></p>"
        },
        {
          "id": 40848,
          "text": "<p><span style=\"font-size:12pt;\">Borderline leprosy&nbsp;(BB Leprosy)</span></p>"
        },
        {
          "id": 40849,
          "text": "<p><span style=\"font-size:12pt;\">Histoid leprosy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">The below-given image is characteristically seen in which of the following type of leprosy? (</span>INICET Nov 2021)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13554.jpg\" alt=\"\" width=\"300\" height=\"200\"></p>",
      "unique_key": "Q5940572",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390868,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;C) Borderline leprosy (BB Leprosy)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given image shows a case of <strong>borderline leprosy, or dimorphous</strong> leprosy, as evidenced by the <strong>inverted saucer</strong> shaped cutaneous lesions on the patient's skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Characteristics of Borderline Leprosy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Lesions:&nbsp;</strong>Borderline leprosy often presents with numerous skin lesions which may be macular (flat), papular (raised), or annular (ring-shaped) with less defined borders compared to tuberculoid leprosy. The lesions can sometimes exhibit an \"inverted saucer\" appearance, where the center appears slightly depressed.</span></li><li><span style=\"font-size:12pt;\"><strong>Symmetry:&nbsp;</strong>The lesions tend to be asymmetrical.</span></li><li><span style=\"font-size:12pt;\"><strong>Sensory Loss:&nbsp;</strong>These lesions usually show some sensory loss, although not as pronounced as in tuberculoid leprosy.</span></li><li><span style=\"font-size:12pt;\"><strong>Reactivity:&nbsp;</strong>Borderline leprosy is particularly unstable immunologically, prone to reactivations and shifts toward either more or less severe forms, depending on immune changes in the individual.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Borderline Tuberculoid Leprosy:&nbsp;</strong>Closer to the tuberculoid pole with fewer, well-defined lesions and significant nerve involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Lepromatous Leprosy:&nbsp;</strong>At the opposite pole from tuberculoid leprosy, characterized by numerous lesions including nodules and plaques, with a high bacterial load but minimal sensory loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Histoid Leprosy:&nbsp;</strong>A rare variant of lepromatous leprosy presenting as nodules and plaques, often occurring in patients who have experienced leprosy treatment or relapse.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Patients with borderline leprosy are at risk for developing reactions like Type 1 (reversal) reactions, which can lead to rapid worsening of lesions and require immediate medical attention.</span></li><li><span style=\"font-size:12pt;\">Accurate diagnosis based on clinical presentation, bacterial index, and histopathology is crucial as the treatment duration and regimen may differ based on the type of leprosy. Borderline leprosy is typically treated with multi-drug therapy (MDT), similar to other forms of leprosy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of Dermatology 9<sup>th</sup> edition page no 28.3, 28.5, 28.10</strong></span></p>",
      "correct_choice_id": 40848,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51012,
      "choices": [
        {
          "id": 203581,
          "text": "<p><span style=\"font-size:12pt;\">ii and iv</span></p>"
        },
        {
          "id": 203582,
          "text": "<p><span style=\"font-size:12pt;\">i, ii, and iv</span></p>"
        },
        {
          "id": 203583,
          "text": "<p><span style=\"font-size:12pt;\">i and iii</span></p>"
        },
        {
          "id": 203584,
          "text": "<p><span style=\"font-size:12pt;\">iii and iv</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The fibres of the internal oblique muscle and transversus abdominus muscle contribute to which boundaries of the inguinal canal walls? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023)</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:12pt;\">Anterior wall</span></li><li><span style=\"font-size:12pt;\">Roof</span></li><li><span style=\"font-size:12pt;\">Floor</span></li><li><span style=\"font-size:12pt;\">Posterior wall</span></li></ol>",
      "unique_key": "Q9466938",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390869,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) ii and iv</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-03-170131.png\" alt=\"\" width=\"600\" height=\"326\"></strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/whatsapp-image-2024-07-04-at-123537-pm.jpeg\" alt=\"\" width=\"500\" height=\"432\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The inguinal canal is an important structure in the anterior abdominal wall, with specific boundaries formed by different layers of muscles and fascia. The internal oblique is present in the lateral 1/3rd of anterior wall but transverse abdominis does not contribute to the anterior wall at all.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>ii. Roof:</strong> The fibres of the internal oblique and transversus abdominis muscles, along with their conjoint tendon, form the roof of the inguinal canal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>iv. Posterior wall:</strong> The conjoint tendon, formed by the joining of the internal oblique and transversus abdominis muscles, also contributes to the posterior wall of the inguinal canal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>i. Anterior wall:</strong> The anterior wall of the inguinal canal is primarily formed by the external oblique aponeurosis, along with skin and superficial fascia. The internal oblique and transversus abdominis muscles do not contribute to the anterior wall.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>iii. Floor:</strong> The floor of the inguinal canal is formed by the inguinal ligament, not by the internal oblique or transversus abdominis muscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The internal oblique and transversus abdominis muscles contribute to the roof and posterior wall of the inguinal canal through their conjoint tendon.</span></p>",
      "correct_choice_id": 203581,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9929,
      "choices": [
        {
          "id": 39682,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Factor XII</span></span></span></p>"
        },
        {
          "id": 39683,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Factor VII</span></span></span></p>"
        },
        {
          "id": 39684,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Factor VIII</span></span></span></p>"
        },
        {
          "id": 39685,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">VWF</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the factor &#39;L&#39; which combines with tissue factor to activate factor IX in given coagulation cascade? (AIIMS MAY 2021)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture20.jpg\" style=\"height:177px; width:300px\" /></p>",
      "unique_key": "Q9813896",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390870,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Factor VII</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The factor marked as &#39;L&#39; is factor VII, which combines with tissue factor to activate factor IX.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture21.jpg\" style=\"height:303px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thrombin also activates factor XIlI, which is the fibrin stabilizing factor to factor XIlla. This factor XIlla forms covalent cross-links and thereby stabilizes the fibrin clot.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Factor XII</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Involved in the initiation of the intrinsic pathway, but it does not combine with tissue factor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Factor VIII</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Works as a cofactor for Factor IXa in the intrinsic pathway, but it does not combine with tissue factor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. VWF (Von Willebrand Factor)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Involved in platelet adhesion and stabilization of Factor VIII but is not involved in the activation of the coagulation cascade by tissue factor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Factor VII is the key clotting factor that combines with tissue factor to activate Factor IX and Factor X, playing a crucial role in the extrinsic pathway of the coagulation cascade.</span></span></span></p>",
      "correct_choice_id": 39683,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13904,
      "choices": [
        {
          "id": 55577,
          "text": "<p><span style=\"font-size:12.0pt;\">C4</span></p>"
        },
        {
          "id": 55578,
          "text": "<p><span style=\"font-size:12.0pt;\">C5</span></p>"
        },
        {
          "id": 55579,
          "text": "<p><span style=\"font-size:12.0pt;\">C6</span></p>"
        },
        {
          "id": 55580,
          "text": "<p><span style=\"font-size:12.0pt;\">C7</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient is unable to abduct his arm. Which of the following root values is likely to be affected? (</span>INICET Nov 2020)</p>",
      "unique_key": "Q3861989",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390871,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. C5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most likely cause of the inability to abduct the arm is a C5 root lesion.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">The C5 spinal nerve plays a crucial role in controlling shoulder abduction. It gives rise to the axillary nerve, which innervates the deltoid muscle. Damage or compression of the C5 nerve root or axillary nerve can result in weakness or paralysis of the deltoid muscle, leading to difficulty in abducting the arm.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Deltoid is supplied by axillary nerve which has the root value of C4-C6. The C5 component is responsible for abduction.Other components help in flexion and extensionm at shoulder joint</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option A.&nbsp;C4:</strong> The C4 spinal nerve does not directly innervate the muscles responsible for shoulder abduction. It primarily supplies sensory information to areas of the neck and upper shoulders.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option C</strong>. <strong>C6:</strong> The C6 spinal nerve primarily innervates the muscles responsible for elbow flexion and wrist extension, not shoulder abduction. Damage to the C6 nerve root would affect these functions rather than shoulder abduction.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option D</strong>. <strong>C7: </strong>The C7 spinal nerve primarily innervates the muscles responsible for elbow and wrist flexion and finger extension. It is not directly involved in shoulder abduction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Muscles of the shoulder</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-171540.jpg\" alt=\"\" width=\"1000\" height=\"1022\"></p>",
      "correct_choice_id": 55578,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44033,
      "choices": [
        {
          "id": 175787,
          "text": "<p><span style=\"font-size:12pt;\">Orientia</span></p>"
        },
        {
          "id": 175788,
          "text": "<p><span style=\"font-size:12pt;\">Babesia</span></p>"
        },
        {
          "id": 175789,
          "text": "<p><span style=\"font-size:12pt;\">Ehrlichia</span></p>"
        },
        {
          "id": 175790,
          "text": "<p><span style=\"font-size:12pt;\">Crimean congo hemorrhagic fever</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following diseases is not transmitted by the vector shown below? (INICET NOV 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/16/screenshot-2024-05-16-183846_IThTtkD.JPG\" alt=\"\" width=\"300\" height=\"335\"></span></p>",
      "unique_key": "Q2088797",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390872,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Orientia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Orientia, the causative agent of scrub typhus, is transmitted by chigger mites, not by the tick shown in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Babesia</strong>: Transmitted by ticks</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Ehrlichia</strong>: Also transmitted by ticks</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D</strong>. <strong>Crimean congo hemorrhagic fever</strong> : Also transmitted by ticks</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Orientia tsutsugamushi, responsible for scrub typhus, is not transmitted by ticks but by chigger mites, distinguishing it from other tick-borne infections like Babesia and Ehrlichia.</span></p>",
      "correct_choice_id": 175787,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23213,
      "choices": [
        {
          "id": 92816,
          "text": "<p><span style=\"font-size:12.0pt;\">Rothera’s Test</span></p>"
        },
        {
          "id": 92817,
          "text": "<p><span style=\"font-size:12.0pt;\">Benedict’s test</span></p>"
        },
        {
          "id": 92818,
          "text": "<p><span style=\"font-size:12.0pt;\">Seliwanoff’s Test</span></p>"
        },
        {
          "id": 92819,
          "text": "<p><span style=\"font-size:12.0pt;\">Biuret Test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 15-year-old boy, a known case of type I DM, undergoes the following test for the detection of KB. Which is this test:&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q7721524",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390873,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Rothera's Test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The test used for the detection of ketone bodies (KB) in the given scenario of a 15-year-old boy with type I diabetes mellitus is <strong>Rothera's Test.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rothera's Test involves the reaction of acetoacetate with sodium nitroprusside and glycine in an alkaline medium. This reaction forms a purple-colored complex, indicating the presence of ketone bodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.&nbsp;<strong>Benedict's test </strong>is used to detect the presence of reducing sugars, such as glucose, in a solution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Seliwanoff's test</strong> is used to differentiate between different types of sugars, particularly distinguishing ketoses from aldoses.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Biuret test</strong>&nbsp;The Biuret test is used to detect the presence of proteins in a sample by reacting with peptide bonds.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rothera's Test is a commonly used laboratory test to detect the presence of ketone bodies, specifically acetoacetate, in urine or blood samples. It is particularly relevant in the context of diabetes mellitus, as individuals with uncontrolled diabetes, especially type I diabetes, may experience an increase in ketone production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In type I diabetes, the body is unable to produce sufficient insulin, resulting in a lack of glucose utilization by cells for energy. As a result, the body begins to break down fats as an alternative energy source, leading to the production of ketone bodies, including acetoacetate.</span></p>",
      "correct_choice_id": 92816,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3060,
      "choices": [
        {
          "id": 12225,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myoglobin</span></span></span></p>"
        },
        {
          "id": 12226,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fetal hemoglobin</span></span></span></p>"
        },
        {
          "id": 12227,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Carbon monoxide poisoning</span></span></span></p>"
        },
        {
          "id": 12228,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acidosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Identify the left curve, given the fact that the right curve is of adult hemoglobin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212529\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture6_yokrhNY.jpg\" style=\"height:350px; width:350px\" /></span></span></span></p>",
      "unique_key": "Q4363962",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390874,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Myoglobin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The left curve is for myoglobin as it is a rectangular hyperbola curve which is characteristic of Michaelis Menton kinetics.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fetal hemoglobin, CO poisoning and acidosis will shift the sigmoidal shape of hemoglobin saturation curve as shown in the image below:</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:#212529\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture7_N22vVT4.jpg\" style=\"height:327px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Fetal hemoglobin:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fetal hemoglobin has a higher affinity for oxygen than adult hemoglobin, which shifts the curve to the left. However, the curve still maintains a sigmoidal shape.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Carbon monoxide poisoning:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Carbon monoxide binds to hemoglobin with a much higher affinity than oxygen, shifting the hemoglobin dissociation curve to the left and making it more difficult for oxygen to be released to tissues. This also retains the sigmoidal shape.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Acidosis:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acidosis generally causes a rightward shift of the hemoglobin oxygen dissociation curve, reducing hemoglobin&#39;s affinity for oxygen. This is the opposite of what is observed with myoglobin.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The left shift observed in the myoglobin curve reflects its high affinity for oxygen, distinguishing it from the sigmoidal curves seen in hemoglobin variations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myoglobin has a hyperbolic oxygen dissociation curve due to its single polypeptide chain and high oxygen affinity, contrasting with the sigmoidal curve of hemoglobin due to its cooperative binding.</span></span></span></p>",
      "correct_choice_id": 12225,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6698,
      "choices": [
        {
          "id": 26761,
          "text": "<p><span style=\"font-size:12.0pt;\">Haloperidol</span></p>"
        },
        {
          "id": 26762,
          "text": "<p><span style=\"font-size:12.0pt;\">Lorazepam</span></p>"
        },
        {
          "id": 26763,
          "text": "<p><span style=\"font-size:12.0pt;\">Clonidine</span></p>"
        },
        {
          "id": 26764,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A psychotic patient developed voluntary purposeless movements and was once observed to be standing still for hours with waxy flexibility and negativism. What is the appropriate medical management?</span></p>",
      "unique_key": "Q4239179",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390875,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Lorazepam</strong></span></p><p><span style=\"font-size:10.5pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">The patient's presentation suggests catatonia, which can manifest with features like waxy flexibility, negativism, and purposeless movements.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lorazepam is a first-line treatment for catatonia. It often provides rapid relief of symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Haloperidol </strong>is an antipsychotic that can be used in psychotic disorders, but it is not the first-line treatment for catatonia. Additionally, antipsychotics might exacerbate or even induce catatonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Clonidine and Option D.</strong> <strong>Propranolol </strong>are not used as primary treatments for catatonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Catatonia is a neuropsychiatric syndrome that can manifest with features like waxy flexibility, negativism, and purposeless movements. Lorazepam is a first-line treatment for catatonia and can provide rapid symptom relief. ECT is considered to be the treatment of choice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: A Short Textbook of Psychiatry, 7th edition, Page No 59, 67.</strong></span></p>",
      "correct_choice_id": 26762,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54515,
      "choices": [
        {
          "id": 217529,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis</span></p>"
        },
        {
          "id": 217530,
          "text": "<p><span style=\"font-size:12.0pt;\">Filariasis</span></p>"
        },
        {
          "id": 217531,
          "text": "<p><span style=\"font-size:12.0pt;\">Malaria</span></p>"
        },
        {
          "id": 217532,
          "text": "<p><span style=\"font-size:12.0pt;\">Syphilis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following STD is transmitted by all components of the blood?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q5551553",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390876,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;D) Syphilis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Syphilis is a sexually transmitted disease (STD) caused by the bacterium Treponema pallidum. It can be transmitted through various means, including sexual contact, from mother to child during childbirth, and through blood transfusions. Syphilis can be transmitted by all components of the blood, making it a comprehensive risk in blood transfusion contexts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While other infections like hepatitis B and C, malaria, and HIV can also be transmitted through blood transfusions, the question specifically asks for an STD. Among the options given, syphilis is the only STD that fits this criterion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hepatitis</strong>: Incorrect because while hepatitis B and C can be transmitted through blood transfusions, they are not classified primarily as sexually transmitted diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Filariasis</strong>: Incorrect because filariasis is a parasitic disease transmitted by mosquitoes, not through blood transfusions or as an STD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Malaria</strong>: Incorrect because malaria is a parasitic infection transmitted by mosquitoes and through blood transfusions, but it is not an STD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Syphilis, caused by Treponema pallidum, is an STD that can be transmitted by all components of the blood, highlighting the importance of thorough blood screening.</span></p>",
      "correct_choice_id": 217532,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13988,
      "choices": [
        {
          "id": 55913,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI Abdomen</span></p>"
        },
        {
          "id": 55914,
          "text": "<p><span style=\"font-size:12.0pt;\">USG Abdomen</span></p>"
        },
        {
          "id": 55915,
          "text": "<p><span style=\"font-size:12.0pt;\">СЕСТ</span></p>"
        },
        {
          "id": 55916,
          "text": "<p><span style=\"font-size:12.0pt;\">Exploratory laparotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 3-month-old child was brought with complaints of umbilical discharge. Abdominal examination was otherwise normal except for the below finding. The next step of management is: (AIIMS MAY 2018)</span></p><p>&nbsp;</p><p><span style=\"font-size:11.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-89_3BO2aHs.jpg\" alt=\"\" width=\"300\" height=\"232\"></span></p>",
      "unique_key": "Q6944174",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390877,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) USG Abdomen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image is that of a congenital umbilical anomaly with an apparent discharging sinus. The given clinical scenario is suggestive of embryonal umbilical anomalies such as patent urachus, urachal cyst, and vitelline cyst (resulting from the persistence of omphalomesenteric duct). The next best step in the management of this case is USG abdomen to diagnose if the anomaly is cystic, fibrous, or of fistula.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ultrasonography (USG) of the abdomen is a safe and non-invasive imaging technique commonly used to evaluate abdominal conditions in pediatric patients. It is particularly useful for assessing the umbilical region and identifying any abnormalities that may be causing the umbilical discharge. USG provides real-time imaging and can help in diagnosing conditions such as umbilical granulomas, urachal abnormalities, or other underlying issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>MRI Abdomen</strong>: MRI (Magnetic Resonance Imaging) of the abdomen is a valuable diagnostic tool for various abdominal conditions. However, in the case of a 3-month-old child with umbilical discharge, an ultrasound (USG) is typically the initial imaging modality of choice. MRI is generally reserved for more complex or specific cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>СЕСТ</strong>: CECT may be done after USG if further information was desired.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Exploratory laparotomy</strong>: Performing an exploratory laparotomy as the initial step in a 3-month-old child with umbilical discharge and an otherwise normal abdominal examination would be overly aggressive and not indicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Omphalomesenteric duct abnormalities:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Vitello intestinal duct or omphalomesenteric duct is the connection between yolk sac and the midgut during embryonic life, which eventually gets obliterated.</span></li><li><span style=\"font-size:12.0pt;\">The persistence of the vitellointestinal duct can lead to various abnormalities according to the part of the duct that is persistent.</span></li><li><span style=\"font-size:12.0pt;\">Persistence of the proximal intestinal end of the duct leads to Meckel's diverticula.</span></li><li><span style=\"font-size:12.0pt;\">Persistence of the distal end near umbilicus leads to umbilical sinus, likely to be the case here.</span></li><li><span style=\"font-size:12.0pt;\">Fully patent vitellointestinal duct can lead to enterocutaneous fistula.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/09/whatsapp-image-2024-09-09-at-60623-pm.jpeg\" alt=\"\" width=\"600\" height=\"160\"></span></p>",
      "correct_choice_id": 55914,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11703,
      "choices": [
        {
          "id": 46778,
          "text": "<p><span style=\"font-size:12.0pt;\">Total blood count with peripheral smear</span></p>"
        },
        {
          "id": 46779,
          "text": "<p><span style=\"font-size:12.0pt;\">CT thorax</span></p>"
        },
        {
          "id": 46780,
          "text": "<p><span style=\"font-size:12.0pt;\">Start cyclophosphamide</span></p>"
        },
        {
          "id": 46781,
          "text": "<p><span style=\"font-size:12.0pt;\">Urgent referral to RT</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 53-year-old patient was admitted complains of dyspnea. On examination he has puffy face, with engorged veins over the chest. SVC obstruction is suspected. Chest X-ray shows mediastinal enlargement. What is the next step? (AIIMS NOV 2018)</span></p>",
      "unique_key": "Q7216020",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390878,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) CT thorax</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Superior Vena Cava (SVC) obstruction, suggested by symptoms like dyspnea, facial puffiness, and engorged chest veins, along with a chest X-ray showing mediastinal enlargement, requires further detailed imaging to accurately assess the extent of the obstruction and the presence of any mediastinal masses. A CT scan of the thorax is the most appropriate next step as it provides detailed images of the chest's anatomy, helping to identify the cause of the SVC obstruction, which is crucial for planning appropriate management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Total blood count with peripheral smear:&nbsp;</strong>While useful for general health assessments and diagnosing blood disorders, this does not directly address the structural issues seen in SVC obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Start cyclophosphamide:&nbsp;</strong>Beginning chemotherapy like cyclophosphamide would only be appropriate after a specific diagnosis of a malignancy causing the SVC obstruction, confirmed via imaging and biopsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Urgent referral to RT:&nbsp;</strong>Referral for radiation therapy (RT) may be necessary if a malignancy is confirmed, but it is premature without a detailed thoracic CT and biopsy if indicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CT thorax is critical for detailed evaluation in suspected SVC obstruction to confirm the diagnosis and guide further specific treatment, whether surgical, medical, or radiation therapy.</span></p>",
      "correct_choice_id": 46779,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11180,
      "choices": [
        {
          "id": 44686,
          "text": "<p><span style=\"font-size:18px;\">Case control study</span></p>"
        },
        {
          "id": 44687,
          "text": "<p><span style=\"font-size:18px;\">Cohort study</span></p>"
        },
        {
          "id": 44688,
          "text": "<p><span style=\"font-size:18px;\">Cross-sectional study</span></p>"
        },
        {
          "id": 44689,
          "text": "<p><span style=\"font-size:18px;\">Clinical trial</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Imagine being part of a team aiming to identify the link between a novel nutritional supplement and its potential effects on muscle growth. You're tasked with deciding the most appropriate study design to establish a cause-and-effect relationship. Among the given options, which study design would be the most effective for demonstrating a connection between cause and effect? </strong><i><strong>[INICET NOV 2021]</strong></i></span></p>",
      "unique_key": "Q1464857",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390879,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Cohort study</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Cohort study is the most effective study design for showcasing the connection between a cause and an effect. A cohort study is a type of analytical (observational) study used for ‘hypothesis testing’. It is known by several synonyms:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:18px;\">Prospective study</span></li><li><span style=\"font-size:18px;\">Forward looking study</span></li><li><span style=\"font-size:18px;\">Cause to effect study</span></li><li><span style=\"font-size:18px;\">Exposure to outcome study</span></li><li><span style=\"font-size:18px;\">Risk factor to disease study</span></li><li><span style=\"font-size:18px;\">Incidence study</span></li><li><span style=\"font-size:18px;\">Follow up study</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Case-control study:&nbsp;</strong>Case Control Study cannot provide with incidences, so Relative Risk cannot be calculated; In a Case Control Study, we calculate ‘an estimate of Relative Risk’, known as ‘Odds Ratio’ (CROSS PRODUCT RATIO).</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Cross sectional study:</strong> A cross-sectional study is based on the single examination of a cross-section of a population ‘at one point of time’, results of sample are then projected to whole population. It cannot establish causality as ‘does not establish time sequence’.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Clinical trials:</strong> Clinical trials evaluates new studies, drugs and treatment effects on human population.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Cohort studies are ideal for establishing cause-and-effect relationships by following exposures over time and observing outcomes.</span></li></ul>",
      "correct_choice_id": 44687,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5981,
      "choices": [
        {
          "id": 23894,
          "text": "<p><span style=\"font-size:12pt;\">Inhibin B</span></p>"
        },
        {
          "id": 23895,
          "text": "<p><span style=\"font-size:12pt;\">Unconjugated Estriol (E3)</span></p>"
        },
        {
          "id": 23896,
          "text": "<p><span style=\"font-size:12pt;\">AFP</span></p>"
        },
        {
          "id": 23897,
          "text": "<p><span style=\"font-size:12pt;\">hCG</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not included in the quadruple screening test?&nbsp;</span>(INICET NOV 2021)</p>",
      "unique_key": "Q1234441",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390880,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Inhibin B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The triple and Quadruple test are done between 15 – 21 weeks.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Components of Triple test are: Free β hCG, unconjugated Estriol (uE3) and Maternal Serum α-fetoprotein.</span></li><li><span style=\"font-size:12pt;\">Components of the Quadruple test are: Free β hCG, unconjugated Estriol (uE3), Maternal Serum α-fetoprotein. And Inhibin A.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/untitled-279.jpg\" alt=\"\" width=\"900\" height=\"274\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">*Easy to remember: <strong>B</strong> for <strong>B</strong>ig; so in Down’s syndrome; <strong>B</strong>eta hCG and Inhi<strong>B</strong>in A: <strong>B</strong>ig/ Increased</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The quadruple screening test includes Free β hCG, unconjugated Estriol (uE3), Maternal Serum α-fetoprotein (AFP), and Inhibin A. Inhibin B is not included in the quadruple test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23894,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24713,
      "choices": [
        {
          "id": 98813,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of angiogenesis</span></p>"
        },
        {
          "id": 98814,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in IL-2, IL-4 and IL-5</span></p>"
        },
        {
          "id": 98815,
          "text": "<p><span style=\"font-size:12.0pt;\">Generation of oxygen free radicals</span></p>"
        },
        {
          "id": 98816,
          "text": "<p><span style=\"font-size:12.0pt;\">Binding to cereblon</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Mechanism of thalidomide teratogenicity include all except</span></p>",
      "unique_key": "Q1834330",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390881,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Increase in IL-2, IL-4 and IL-5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thalidomide actually suppresses the production of certain cytokines, including IL-2, IL-4, and IL-5. The suppression of these interleukins is part of its immunomodulatory effects, not a mechanism of teratogenicity. Thalidomide suppresses the production of interleukins which is an important mechanism in treatment of multiple myeloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The exact mechanism of thalidomide's teratogenicity is not completely understood, but several mechanisms have been proposed:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Inhibition of angiogenesis</strong>: Thalidomide has been found to inhibit angiogenesis, which is the formation of new blood vessels. This inhibition can disrupt the development of the fetus, leading to birth defects. This mechanism is widely accepted as a significant contributor to the teratogenic effects of thalidomide.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Generation of oxygen free radicals</strong>: Thalidomide may cause oxidative stress by generating oxygen free radicals, which can damage developing cells. This oxidative stress can contribute to teratogenic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Binding to cereblon</strong>: Recent studies have shown that thalidomide binds to a protein called cereblon, which is involved in limb outgrowth and ear development. When thalidomide binds to cereblon, it disrupts the normal function of this protein, leading to the birth defects associated with thalidomide use.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Other mechanism includes -</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Interference with cellular signalling:</strong> Thalidomide may interfere with various cellular signalling pathways, such as those involving fibroblast growth factors, which are important for embryonic development.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thalidomide's teratogenicity is primarily associated with mechanisms such as the inhibition of angiogenesis, generation of oxygen free radicals, and binding to the cereblon protein. It does not cause an increase in IL-2, IL-4, and IL-5; in fact, it suppresses these interleukins.</span></p>",
      "correct_choice_id": 98814,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10232,
      "choices": [
        {
          "id": 40894,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 40895,
          "text": "<p><span style=\"font-size:12pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 40896,
          "text": "<p><span style=\"font-size:12pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 40897,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Chemoprophylaxis for leprosy should be given to which of the following persons?</span>(INICET NOVEMBER 2022)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Sharing the same clothes, towels</span></li><li><span style=\"font-size:12pt;\">Living with a patient with leprosy for &gt; 6 month</span></li><li><span style=\"font-size:12pt;\">Contact of age more than 2 years</span></li><li><span style=\"font-size:12pt;\">Contact for more than 20 hours per week.&nbsp;</span></li></ol><p>&nbsp;</p>",
      "unique_key": "Q6839710",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390882,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Chemoprophylaxis for leprosy should be given to contacts 2, 3 and 4.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Chemoprophylaxis for leprosy should be given to the following contacts:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Being identified as a contact, i.e., a person who has been in close contact with the index case for <strong>20 hours (option 4) or more per week for more than 3 months</strong> <strong>(option 2)</strong> (Exception is <strong>blanket approach</strong> where no link with an index case needs to be established.)</span></li><li><span style=\"font-size:12pt;\"><strong>Age:</strong>&nbsp;<strong>More than 2 years (option 3);</strong> if younger than 2 years, the child can be given SDR at the age of 2, in follow up visits of contacts (if meeting all other inclusion criteria.)</span></li><li><span style=\"font-size:12pt;\"><strong>Consent of the contact obtained</strong>. Depending on the country situation, this can be <strong>written</strong> or a <strong>verbal consent</strong>. In case of children, consent should be obtained from the <strong>parent</strong> or <strong>guardian,</strong> and sometimes an <strong>assent</strong> from the <strong>grown-up</strong> <strong>children.</strong></span></li><li><span style=\"color:#0f0f0f;font-size:12pt;\"><strong>Sharing&nbsp;</strong>the same <strong>clothes and</strong> <strong>towels (Option 1),</strong> while a potential <strong>route of transmission</strong>, is <strong>not</strong> generally considered a primary <strong>criterion</strong> for <strong>chemoprophylaxis.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Exclusion criteria</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12pt;\">Persons with possible signs and/or symptoms of <strong>leprosy;</strong></span></li><li><span style=\"color:black;font-size:12pt;\">Persons with possible signs and/or symptoms of <strong>TB</strong> <strong>or confirmed with TB;</strong></span></li><li><span style=\"color:black;font-size:12pt;\">Persons with a history of <strong>liver or kidney disorders</strong>;</span></li><li><span style=\"color:black;font-size:12pt;\"><strong>Pregnancy</strong>; SDR can be <strong>given after the delivery</strong>;</span></li><li><span style=\"color:black;font-size:12pt;\">Persons who have received <strong>rifampicin in the last two years</strong> e.g. as treatment of TB, leprosy or as prophylaxis (e.g. contact of another index case);</span></li><li><span style=\"color:black;font-size:12pt;\">Persons with history of <strong>allergy to rifampicin</strong>;</span></li><li><span style=\"color:black;font-size:12pt;\"><strong>Refusal to take SDR.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Chemoprophylaxis for leprosy is crucial for contacts who have had significant exposure to an individual with leprosy, particularly those living in the same household or in close contact for extended periods.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Rifampicin:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">A <strong>single dose of 600 mg</strong> kills more than <strong>99%</strong> of the <strong>susceptible organisms</strong> present at the start of treatment, that is as much as <strong>3 to 6 months</strong> of daily treatment with the combination <strong>dapsone plus Clofazimine.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Rifampicin&nbsp;</strong>has become established as a <strong>highly potent bactericidal drug</strong>, and it acts by <strong>inhibiting</strong> the <strong>bacterial DNA dependent RNA polymerase</strong>.</span></li><li><span style=\"color:black;font-size:12pt;\"><strong>Single Dose of Rifampicin&nbsp;</strong>(SDR) is used in <strong>chemoprophylaxis.</strong></span></li><li><span style=\"color:black;font-size:12pt;\">Chemoprophylaxis must be initiated only <strong>4 weeks after treatment for leprosy</strong> has begun in the <strong>patient</strong> so as to ensure the <strong>patient is non-infectious</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><i><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/screenshot-2023-11-22-160933.jpg\" alt=\"\" width=\"1000\" height=\"405\"></i></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref -&nbsp;</strong></span><span style=\"color:black;font-size:12pt;\"><strong>Jopling’s Handbook of Leprosy 6<sup>th</sup> Edition Page no 242</strong></span></p><p><span style=\"color:#3c4245;font-size:12pt;\"><strong>Leprosy/Hansen disease: Contact tracing and post-exposure prophylaxis</strong></span></p><p><a href=\"https://www.who.int/publications/i/item/9789290228073\"><span style=\"font-size:12pt;\"><strong><u>https://www.who.int/publications/i/item/9789290228073</u></strong></span></a><span style=\"font-size:12pt;\"><strong> (page 23, 24)</strong></span></p><p><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051288/\"><span style=\"font-size:12pt;\"><strong><u>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051288/</u></strong></span></a></p>",
      "correct_choice_id": 40896,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9849,
      "choices": [
        {
          "id": 39362,
          "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Light green SF</span></span></span></p>"
        },
        {
          "id": 39363,
          "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Orange G</span></span></span></p>"
        },
        {
          "id": 39364,
          "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Eosin B</span></span></span></p>"
        },
        {
          "id": 39365,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Hematoxylin</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a component of Papanicolaou stain? </span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(AIIMS MAY 2020)</span></span></p>",
      "unique_key": "Q5625264",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390883,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Eosin B</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Eosin B is not a component of Papanicolaou stain</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Papanicolaou stain is the most popular stain used in the practice of histopathology. It is a polychrome stain containing multiple dyes to stain the various components of cells differentially. Papanicolaou stain includes both acidic and basic dyes:</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The classic form of Pap stain involves five dyes in three solutions:</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">A nuclear stain<strong>, hematoxylin</strong>, is used to stain cell nuclei.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">First OG-6 counterstain. The <strong>Orange G</strong> is used to stain keratin.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Second EA (Eosin Azure) counterstain, comprising of three dyes</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Eosin Y</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> stains the superficial epithelial squamous cells, nucleoli, cilia, and red blood cells.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Light Green SF</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> yellowish stains the cytoplasm of all other cells. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Bismarck brown Y</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> &ndash; omitted in contemporary formulations</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Light green SF</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This dye is used in the Pap stain to color the cytoplasm of various cells green.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Orange G</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This dye stains keratin and protein-rich components orange.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Hematoxylin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A nuclear stain used to color cell nuclei blue-purple.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Eosin B is not a component of the Papanicolaou stain, which uses a combination of hematoxylin, Orange G, and Eosin Azure (including Eosin Y and Light Green SF) to differentially stain cellular components.</span></span></span></p>",
      "correct_choice_id": 39364,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10226,
      "choices": [
        {
          "id": 40870,
          "text": "<p><span style=\"font-size:12pt;\">Stop MDT and start oral steroids</span></p>"
        },
        {
          "id": 40871,
          "text": "<p><span style=\"font-size:12pt;\">Antibiotics</span></p>"
        },
        {
          "id": 40872,
          "text": "<p><span style=\"font-size:12pt;\">Thalidomide</span></p>"
        },
        {
          "id": 40873,
          "text": "<p><span style=\"font-size:12pt;\">Continue MDT and add oral steroids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a pregnant woman at 12 weeks of gestation, who is currently undergoing multidrug therapy (MDT) for leprosy, she now presents with type 2 lepra reaction. What is the preferred treatment for this patient?&nbsp;</span>&nbsp;(INICET NOVEMBER 2022)</p>",
      "unique_key": "Q7376877",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390884,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Continue MDT and add oral steroids</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">To manage a <strong>pregnant woman </strong>experiencing a <strong>type 2 lepra reaction</strong>, it is essential to <strong>continue the multidrug therapy (MDT)</strong> while adding <strong>oral steroids </strong>as an <strong>additional</strong> treatment.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">In the management of leprosy, it is crucial to <strong>continue </strong>multidrug therapy <strong>(MDT) </strong>to effectively treat the <strong>underlying infection </strong>caused by <strong>Mycobacterium leprae.</strong></span></li><li><span style=\"font-size:12pt;\">A <strong>Type 2 lepra </strong>reaction, also known as <strong>erythema nodosum leprosum (ENL), </strong>is a complex <strong>immunological reaction </strong>that occurs in <strong>lepromatous and borderline lepromatous leprosy</strong>, which can present with <strong>painful nodules</strong>, <strong>fever, malaise</strong>, and other <strong>systemic </strong>symptoms.</span></li><li><span style=\"font-size:12pt;\"><strong>Oral steroids</strong>, such as <strong>prednisone</strong>, are the treatment of choice for controlling <strong>acute inflammatory complications </strong>associated with Type 2 lepra reaction. They help <strong>reduce inflammation </strong>and <strong>immune</strong> response.</span></li><li><span style=\"font-size:12pt;\">It is important to manage the reaction <strong>without discontinuing </strong>the <strong>MDT</strong> to <strong>prevent </strong>the development of <strong>drug resistance </strong>and further progression of the disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Erythema nodosum leprosum (ENL)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It is a <strong>type 3 hypersensitive immune complex-mediated reaction</strong> that affects the <strong>skin, nerves, and other organs.</strong></span></li><li><span style=\"font-size:12pt;\">It is typically r<strong>ecurrent</strong> and commonly observed in individuals with <strong>multibacillary</strong> leprosy. ENL may occur <strong>before treatment</strong>, <strong>during treatment</strong> or <strong>after</strong> completion of treatment.</span></li><li><span style=\"font-size:12pt;\">It is characterized by <strong>painful, erythematous nodules</strong> appearing on the extensor surfaces of the <strong>limbs and face.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In a type 2 lepra reaction, <strong>systemic symptoms </strong>such as <strong>iritis, orchitis</strong>, and the appearance of <strong>fresh </strong>skin lesions can be observed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Treatment includes:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">High doses of <strong>glucocorticoids</strong> are frequently administered to all patients which assist in <strong>reducing</strong> the acute signs and symptoms of <strong>inflammation.</strong></span></li><li><span style=\"font-size:12pt;\">In patients with lepra reactions, <strong>MDT is never discontinued</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Only severe cases of type-2 lepra reaction or erythema nodosum Leprosum are treated with thalidomide.&nbsp;</strong>Thalidomide is <strong>gold standard for type II Lepra</strong> reaction, but it is <strong>NOT the Drug of Choice</strong> due to its <strong>cost</strong> factor &amp; also its <strong>Adverse drug reactions profile.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Type I &amp; II lepra reactions (ENL= Erythema Nodosum Leprosum):</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-175436.png\" alt=\"\" width=\"900\" height=\"339\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Stop MDT and start oral steroids: </strong>Stopping MDT is <strong>not advisable</strong> because it can lead to the <strong>proliferation</strong> of <strong>Mycobacterium leprae</strong> and risk the development of <strong>drug resistance.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Antibiotics: </strong>While <strong>antibiotics</strong> are a <strong>part of MDT</strong> to treat the <strong>bacterial infection</strong>, they alone are <strong>not sufficient</strong> to address the <strong>acute inflammatory symptoms</strong> of a Type 2 lepra reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Thalidomide:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Thalidomide is an effective treatment for Type 2 lepra reactions due to its potent anti-inflammatory properties.</span></li><li><span style=\"font-size:12pt;\">However, it is <strong>absolutely contraindicated</strong> in <strong>pregnant</strong> women due to its <strong>teratogenic effects</strong>, which can cause <strong>severe birth defects as seen in the below image</strong>.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-175555.png\" alt=\"\" width=\"500\" height=\"618\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Phocomelia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">In a pregnant woman with leprosy who presents with a <strong>Type 2 lepra</strong> reaction, the preferred treatment is to <strong>continue multidrug therapy</strong> and <strong>add oral steroids</strong> to manage the <strong>acute inflammatory symptoms</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Thalidomide&nbsp;</strong>is c<strong>ontraindicated</strong> in pregnancy due to its <strong>teratogenicity.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rook's Textbook of Dermatology -9th Edition Chapter 28 Page no 28.16</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Harrison’s principles of internal medicine 21<sup>st</sup> edition page no 1387, 1390</strong></span></p>",
      "correct_choice_id": 40873,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60829,
      "choices": [
        {
          "id": 242609,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 and 4</span></span></span></p>"
        },
        {
          "id": 242610,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 and 3</span></span></span></p>"
        },
        {
          "id": 242611,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 and 4</span></span></span></p>"
        },
        {
          "id": 242612,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 and 3</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient was brought following an RTA. He was found to have an incomplete lesion of the spinal cord. What would be seen if the central part of the cord was involved?</span> <span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2022)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LMN lesion of upper limbs and trunk and UMN of lower limbs.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">UMN lesion of upper limbs and trunk and LMN of lower limbs.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bladder and bowel involvement.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Posterior tract involvement.</span></span></span></li>\r\n</ol>",
      "unique_key": "Q9824162",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390885,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) 1 and 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this patient with </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">central cord syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LMN lesion of upper limbs and trunk</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">UMN of lower limbs</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, and </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">bladder and bowel</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> involvement will be seen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Central cord syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> results from damage to the </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">central region of the spinal cord</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, specifically affecting the </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">gray matter nerve cells</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> and the </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">decussating spinothalamic tracts</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> surrounding the central canal, which carry crude touch, pain, and temperature sensations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This syndrome commonly occurs due to </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">hyperextension of the cervical spine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, causing compression of the spinal cord. Other causes include </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">spinal trauma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">syringomyelia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, or intrinsic cord tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key clinical features include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arm weakness &gt; leg weakness</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (upper limb motor loss is more severe than lower limb motor loss).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dissociated sensory loss</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, with loss of crude touch, pain, and temperature sense, while proprioception and vibration senses are spared.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral lower motor neuron paralysis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> in the upper limbs and trunk (due to central damage), with upper motor neuron symptoms in the lower limbs.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bladder and bowel dysfunction</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are frequently involved, and </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Horner&rsquo;s syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> can also occur.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition typically spares the </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">posterior column</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, which is responsible for proprioception and fine touch.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 1 and 4: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While the </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LMN lesion of the upper limbs</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is correct, </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">posterior tract involvement</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is incorrect, as the posterior columns (proprioception and vibration) are usually spared in central cord syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. 2 and 3: UMN lesions of the upper limbs and trunk</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> do not occur in central cord syndrome. Central cord syndrome primarily results in </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LMN lesions</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> in the upper limbs, with </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">UMN signs</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> in the lower limbs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. 2 and 4: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This combination incorrectly suggests </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">UMN lesions</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> in the upper limbs and </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">posterior tract involvement</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, which are not features of central cord syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Central cord syndrome</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is characterized by </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">upper limb motor weakness (LMN)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">lower limb UMN signs</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, and </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">bladder and bowel dysfunction</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. It often occurs following hyperextension injuries of the cervical spine and is marked by sensory dissociation (loss of pain and temperature, with sparing of proprioception and fine touch).</span></span></p>",
      "correct_choice_id": 242612,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3673,
      "choices": [
        {
          "id": 14671,
          "text": "<p><span style=\"font-size:12.0pt;\">Mature dendritic cells</span></p>"
        },
        {
          "id": 14672,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicular dendritic cells</span></p>"
        },
        {
          "id": 14673,
          "text": "<p><span style=\"font-size:12.0pt;\">B lymphocytes</span></p>"
        },
        {
          "id": 14674,
          "text": "<p><span style=\"font-size:12.0pt;\">NK cell</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most potent stimulator of naive T-cells?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">NOV 2018)</span></p>",
      "unique_key": "Q3324362",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390886,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Mature dendritic cells</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mature dendritic cells are the most potent stimulator of naive T cells as they possess higher levels</strong> <strong>of MHC-II</strong>. They also have costimulatory membrane proteins which are required for activation of T cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Follicular dendritic cells</strong> are functionally different from dendritic cells. They are <strong>not antigen-presenting-cells and do not activate naive T cells.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-19.jpg\" alt=\"\" width=\"700\" height=\"961\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. B lymphocytes:</strong> While B cells can act as antigen-presenting cells, they are not as effective as dendritic cells in stimulating naive T cells. They typically present antigens to already activated T cells rather than naive ones.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. NK cell:</strong> Natural killer (NK) cells are involved in the innate immune response and do not function as antigen-presenting cells. They are responsible for recognizing and killing virally infected cells and tumor cells without the need for antigen presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Mature dendritic cells are the most potent stimulators of naive T cells due to their high levels of MHC-II and costimulatory molecules.</span></p>",
      "correct_choice_id": 14671,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9826,
      "choices": [
        {
          "id": 39271,
          "text": "<p><span style=\"font-size:12.0pt;\">Ferroportin</span></p>"
        },
        {
          "id": 39272,
          "text": "<p><span style=\"font-size:12.0pt;\">Divalent metal transporter 1</span></p>"
        },
        {
          "id": 39273,
          "text": "<p><span style=\"font-size:12.0pt;\">Divalent metal transporter 2</span></p>"
        },
        {
          "id": 39274,
          "text": "<p><span style=\"font-size:12.0pt;\">Haptocorrin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which transporter is required for the transport of iron into the enterocyte? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q9431478",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390887,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Divalent metal transporter 1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>DMT1 (divalent metal transporter 1) is required for the transport of iron into the enterocyte.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Luminal nonheme iron is mostly in the Fe [3] + (ferric state and is reduced to Fe [2] + (ferrous) iron by ferrireductases, such as b cytochromes and STEAP3. Fe [2] + iron is then transported across the apical membrane by divalent metal transporter 1 (DMT1).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fe [2] + iron destined for the circulation, is transported from the cytoplasm across the basolateral enterocyte membrane by ferroportin. This process is coupled to the oxidation of Fe [2] + iron to Fe [3] + iron, which is carried out by the iron oxidases hephaestin and ceruloplasmin.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/959.jpg\" alt=\"\" width=\"703\" height=\"451\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ferroportin:</strong> Ferroportin is not involved in the initial transport of iron into the enterocyte. Instead, it is responsible for exporting iron from the enterocyte into the bloodstream. Ferroportin also works in tandem with hephaestin to ensure that Fe²⁺ iron is oxidized to Fe³⁺ before being released into circulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Divalent metal transporter 2:</strong> There is no known transporter named \"Divalent metal transporter 2\" involved in iron absorption or transport within enterocytes. This option is incorrect and may be a distractor or incorrect reference.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Haptocorrin:</strong> Haptocorrin is a protein that binds vitamin B12 (cobalamin) in the stomach, protecting it from degradation. It is not involved in iron transport or metabolism, making this option incorrect in the context of iron absorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Divalent metal transporter 1 (DMT1) is critical for the transport of Fe²⁺ iron across the apical membrane of enterocytes, facilitating iron absorption in the gut.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotrans pathologic basis of disease 8th edition Pg 1230</strong></span></p>",
      "correct_choice_id": 39272,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54533,
      "choices": [
        {
          "id": 217601,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endothelial cells</span></span></span></p>"
        },
        {
          "id": 217602,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parafollicular cells</span></span></span></p>"
        },
        {
          "id": 217603,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Follicular cells</span></span></span></p>"
        },
        {
          "id": 217604,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hurthle cells</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient presents with neck swelling and difficulty in swallowing food. Histopathological examination of the swelling shows increased nests of cells with amyloid deposition. Which of the following is the cell of origin of this mass?&nbsp;</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3442490",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390888,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Parafollicular cells</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Medullary thyroid carcinoma (MTC) is the type of thyroid cancer associated with increased nests of cells and amyloid deposition. MTC arises from the parafollicular cells (also known as C cells) of the thyroid. These cells produce calcitonin, a hormone involved in calcium homeostasis. The presence of amyloid in MTC is due to the deposition of calcitonin, which can be detected as amyloid material in histopathological examinations. This type of thyroid cancer is distinct from other forms such as papillary, follicular, or anaplastic thyroid carcinomas, which originate from follicular cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Endothelial cells: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect. Endothelial cells line blood vessels and are not associated with thyroid tumors that show amyloid deposition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Follicular cells: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect. Follicular cells give rise to papillary, follicular, and anaplastic thyroid cancers, not medullary thyroid carcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Hurthle cells: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect. Hurthle cells are a variant of follicular cells and can be seen in Hurthle cell carcinoma, another type of thyroid cancer, but not in medullary thyroid carcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Medullary thyroid carcinoma, characterized by nests of cells and amyloid deposition, arises from the parafollicular cells (C cells) of the thyroid.</span></span></span></p>",
      "correct_choice_id": 217602,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6881,
      "choices": [
        {
          "id": 27492,
          "text": "<p><span style=\"font-size:12.0pt;\">Binding of ATP</span></p>"
        },
        {
          "id": 27493,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Entry of calcium into sarcoplasmic reticulum</span></p>"
        },
        {
          "id": 27494,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Change in troponin C configuration</span></p>"
        },
        {
          "id": 27495,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Release of ADP and Pi</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Myosin head detaches from actin by which of the following mechanism? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q3317777",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390889,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Binding of ATP</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Binding of ATP on the free site of myosin leads to the detachment of myosin head from the thin filament.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/aiims-physio-nov-2019-04.jpg\" alt=\"\" width=\"1200\" height=\"592\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Energy for movement of myosin head (power stroke) is obtained by breakdown of adenosine triphosphate (ATP) into adenosine diphosphate (ADP) and inorganic phosphate (Pi). Head of myosin has a site for ATP and itself can act as the enzyme ATPase and catalyse the breakdown of ATP.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Even before the onset of contraction, an ATP molecule binds with myosin head.</span></p><p><span style=\"font-size:12.0pt;\">When tropomyosin moves to expose the active sites, the head is attached to the active site. Now ATPase cleaves ATP into ADP and Pi, which remains in head itself. The energy released during this process is utilized for contraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B. Entry of calcium into sarcoplasmic reticulum:</strong> Incorrect. The entry of calcium into the sarcoplasmic reticulum helps in muscle relaxation but does not directly cause the detachment of the myosin head from actin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C. Change in troponin C configuration:</strong> Incorrect. The change in troponin C configuration exposes the active sites on actin for myosin binding but does not cause detachment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D. Release of ADP and Pi:</strong> Incorrect. The release of ADP and Pi occurs after the power stroke but does not cause the detachment of the myosin head.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The detachment of the myosin head from actin is caused by the binding of ATP to the myosin head, which is a critical step in the muscle contraction and relaxation cycle.</span></p>",
      "correct_choice_id": 27492,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13110,
      "choices": [
        {
          "id": 52402,
          "text": "<p><span style=\"font-size:12.0pt;\">Drusen</span></p>"
        },
        {
          "id": 52403,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Hard exudates</span></p>"
        },
        {
          "id": 52404,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Cotton wool spots</span></p>"
        },
        {
          "id": 52405,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Macular Edema</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the lesion in the histopathological image of retina: (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS Nov 2018)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture4_8iF6kej.jpg\" alt=\"\" width=\"400\" height=\"223\"></span></p>",
      "unique_key": "Q2740479",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390890,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A) Drusen&nbsp;</strong>&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Drusen, also called colloid bodies, are <strong>extracellular deposits</strong> located at the interface <strong>between the Retinal Pigmentary Epithelium and Bruch membrane</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Drusen are numerous, minute, whitish, refractile spots with pigmented margins, mainly involving the posterior pole.</span></li><li><span style=\"font-size:12.0pt;\">They are seen in senile macular degeneration and Doyne's honeycomb dystrophy.</span></li><li><span style=\"font-size:12.0pt;\">The material of which they are composed has a broad range of constituents and is thought to be derived from immune-mediated and metabolic processes in the retinal pigmentary epithelium.</span></li><li><span style=\"font-size:12.0pt;\">The precise role of drusen in the pathogenesis of age-related macular degeneration (AMD) is unclear.</span></li><li><span style=\"font-size:12.0pt;\">However, drusen are positively associated with the size of lesions and the presence or absence of associated pigmentary abnormalities.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture5_MaNuYKG.jpg\" alt=\"\" width=\"700\" height=\"590\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Hard exudates:</strong> Well-defined, bright yellow deposits of extravasated fluid rich in fibrin and proteins. These hyaline or lipid deposits are generally seen as a cluster around a group of leaking microaneurysms. Commonly seen in macular area, in the outer plexiform layer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cotton-wool spots:</strong> Composed of accumulations of neuronal debris within the nerve fibre layer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Macular edema:</strong> Accumulation of excess fluid in the extracellular space within the retina in the macular area.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Drusen are distinct, granular deposits at the interface between the retinal pigment epithelium and Bruch's membrane, commonly associated with age-related macular degeneration and can be an early sign of the disease.</span></p>",
      "correct_choice_id": 52402,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11058,
      "choices": [
        {
          "id": 44198,
          "text": "<p><span style=\"font-size:18px;\">50</span></p>"
        },
        {
          "id": 44199,
          "text": "<p><span style=\"font-size:18px;\">100</span></p>"
        },
        {
          "id": 44200,
          "text": "<p><span style=\"font-size:18px;\">150</span></p>"
        },
        {
          "id": 44201,
          "text": "<p><span style=\"font-size:18px;\">200</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>While working at a rural health sub-centre, you and a medical intern are analyzing annual infant registration metrics. The intern inquires about the expected annual infant registration rate when a health worker is actively on duty at the sub center. What is the best representation of this rate? </strong><i><strong>[AIIMS MAY 2018]</strong></i></span></p>",
      "unique_key": "Q3961896",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390891,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) 150</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Each year, a total of 150 infants should be enrolled at a sub-centre.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Annual infant population = Total population × % infants in population or expected birth rate</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The infant population percentage, or the anticipated birth rate, ought to be derived from local data. In cases where a specific local percentage is not accessible, it is approximated at 3% of the overall population.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Total population in a sub centre = 5000.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Here, annual infant population = 5000 × 3/100 = 150</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Total population catered by a Sub centre = 5000</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Crude birth rate (CBR) India = 19 per 1000 Mid-year population (SRS 2016)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">So, estimated number of births in a year = 19/1000 ×5000 = 95 births per year</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Also, current Infant mortality rate (IMR) India = 28 per 1000 Live births</span></li><li><span style=\"font-size:18px;\">So, Expected number of infant deaths in a year in that population = 28/1000 × 95 = 2.7 deaths</span></li><li><span style=\"font-size:18px;\">So, total number of expected alive infants = 95 – 2.7 = 92 Infants approximately</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">In a rural health sub-centre, the expected annual infant registration rate effectively captures both the births and adjustments for infant mortality.</span></li><li><span style=\"font-size:18px;\">The number 150 serves as a practical target for ensuring all newborns are accounted for within the community health system.</span></li><li><span style=\"font-size:18px;\">This figure supports proactive health planning and resource allocation, emphasizing the importance of accurate and timely health data registration.</span></li></ul>",
      "correct_choice_id": 44200,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24691,
      "choices": [
        {
          "id": 98725,
          "text": "<p><span style=\"font-size:12.0pt;\">Stenotrophomonas maltophila</span></p>"
        },
        {
          "id": 98726,
          "text": "<p><span style=\"font-size:12.0pt;\">Proteus mirabilis</span></p>"
        },
        {
          "id": 98727,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudomonas aeruginosa</span></p>"
        },
        {
          "id": 98728,
          "text": "<p><span style=\"font-size:12.0pt;\">Acinetobacter baumannii</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The microorganism demonstrates resistance to meropenem and aminoglycosides, while being susceptible to ticarcillin-clavulanate and cotrimoxazole. Which microorganism is most likely responsible? (INICET MAY 2023)</span></p>",
      "unique_key": "Q7471642",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390892,
      "difficulty_level": "difficult",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Stenotrophomonas maltophila</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Stenotrophomonas maltophila, previously known as Pseudomonas maltophila, is an opportunistic pathogen responsible for wound infections, urinary tract infections, and septicemia.</span></li><li><span style=\"font-size:12.0pt;\">It displays susceptibility to cotrimoxazole.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Proteus mirabilis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Resistant to: Nitrofurantoin, Tetracyclines</span></li><li><span style=\"font-size:12.0pt;\">Susceptible to aminoglycosides, carbapenems, cephalosporins, cotromoxazole, penicillin+ β-lactamase inhibitors.</span></li><li><span style=\"font-size:12.0pt;\">Clinical manifestations: Respiratory infections, especially in cystic fibrosis patients, and opportunistic infections.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pseudomonas aeruginosa:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Known for resistance to multiple antibiotics, but typically not specifically resistant to meropenem.</span></li><li><span style=\"font-size:12.0pt;\">Susceptible to: A wide range of antibiotics, often including aminoglycosides, depending on the strain.</span></li><li><span style=\"font-size:12.0pt;\">Clinical manifestations: Respiratory infections, wound infections, and urinary tract infections.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Acinetobacter baumannii:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Known for multi-drug resistance, including to carbapenems like meropenem.</span></li><li><span style=\"font-size:12.0pt;\">Susceptibility varies, but generally not as consistently susceptible to ticarcillin-clavulanate as Stenotrophomonas maltophila.</span></li><li><span style=\"font-size:12.0pt;\">Clinical manifestations: Hospital-acquired infections, such as pneumonia and bloodstream infections.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Stenotrophomonas maltophila is an opportunistic pathogen resistant to meropenem and aminoglycosides but susceptible to ticarcillin-clavulanate and cotrimoxazole.</span></p>",
      "correct_choice_id": 98725,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9802,
      "choices": [
        {
          "id": 39175,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Focal segmental glomerulosclerosis (FSGS)</span></span></span></p>"
        },
        {
          "id": 39176,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Post-streptococcal glomerulonephritis (PSG)</span></span></span></p>"
        },
        {
          "id": 39177,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Good pasture syndrome</span></span></span></p>"
        },
        {
          "id": 39178,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus nephritis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A middle-aged male patient has proteinuria. Looking at the immunofluorescence image below, what is the diagnosis? (AIIMS NOV 2018)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/946.jpg\" style=\"height:217px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q6612801",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390893,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Lupus nephritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given immunofluorescence staining of the kidney biopsy specimen shows positive staining for fibrinogen, IgG, IgA, IgM, C1q, C3, &lambda; chain, and k light chain. This is <strong>known as full-house effect</strong>. It is seen in lupus nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Six patterns of lupus nephritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class I - Minimal lesions - deposits within the <u>mesangium p</u>ositive for IgG and C3.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class II &ndash; Mesangial lupus nephritis - Granular <u>mesangial deposits </u>of IgG and C3; sometimes IgA and IgM are also present in the deposits.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class III &ndash; Focal segmental lupus nephritis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Subendothelial and subepithelial deposits of IgG, often with IgM or IgA and C3, are seen.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class IV &ndash; Diffuse lupus nephritis </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&ndash; <strong>Most severe and most common</strong>. Deposits in the mesangium and in the <strong>subendothelial region</strong> which on immunofluorescence are positive for IgG; sometimes also for IgA or IgM, and C3.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class V &ndash; Membranous Lupus Nephritis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - <strong>subendothelial</strong> deposits of immune complexes containing IgG, IgM and C3</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class VI &ndash; Sclerosing Lupus nephritis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - End-stage kidney of SLE. Most glomeruli are sclerosed and hyalinised and there may be remnants of preceding lesions.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Focal segmental glomerulosclerosis (FSGS)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This does not typically show a full-house pattern on immunofluorescence. FSGS is usually characterized by segmental glomerular scarring and may show focal deposits of IgM and C3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Post-streptococcal glomerulonephritis (PSG)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This condition typically shows deposits of IgG and C3 in a &quot;starry sky&quot; pattern on immunofluorescence but does not display a full-house pattern.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Goodpasture syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This typically shows linear deposits of IgG along the glomerular basement membrane, without the full-house pattern seen in lupus nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>full-house effect</strong> on immunofluorescence (positive staining for IgG, IgA, IgM, C1q, C3, &lambda; chain, and &kappa; light chain) is a hallmark of <strong>lupus nephritis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins Pathologic basis of disease 8<sup>th</sup> edition, Pg 409-410</span></strong></span></span></p>",
      "correct_choice_id": 39178,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11711,
      "choices": [
        {
          "id": 46810,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Repeat Inj. adenosine 6 mg</span></span></span></span></p>"
        },
        {
          "id": 46811,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronized cardioversion</span></span></span></span></p>"
        },
        {
          "id": 46812,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inj. amiodarone 300 mg</span></span></span></span></p>"
        },
        {
          "id": 46813,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DC cardioversion</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ECG of a patient who presented to the ER is as given below. The patient was already given a carotid massage and IV Adenosine but the BP is currently 60/30 mm Hg. What is the next best step of management? (AIIMS NOV 2019)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm97.jpg\" style=\"height:296px; width:700px\" /></span></span></span></span></p>",
      "unique_key": "Q1327024",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390894,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronized Cardioversion</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Any hemodynamically unstable rhythm, requires synchronized cardioversion (Shock delivered in sync with R wave to prevent R-on T phenomenon). </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronized Cardioversion&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the correct choice for a hemodynamically unstable patient, as it is intended to restore normal heart rhythm without causing further cardiac risks. Synchronization ensures that the shock is delivered at a safe point in the QRS complex to prevent the induction of ventricular fibrillation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maximum of 30mg of adenosine can be tried if patient is <em>Hemodynamically Stable</em></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amiodarone is used in the treatment of chronic arrhythmias and rarely for acute treatment of SVT</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DC cardioversion&nbsp;</span></strong>technically refers to the same treatment as synchronized cardioversion in the context of unstable rhythms but the lack of specification about synchronization could imply a risk if not properly timed.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronised cardioversion avoid possibility of R on T phenomenon.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/11/screenshot-2024-09-11-112319.png\" style=\"height:445px; width:1000px\" /></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm118.jpg\" style=\"height:364px; width:700px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of hemodynamically unstable tachyarrhythmias where initial pharmacological interventions fail, synchronized cardioversion should be promptly employed to stabilize the patient. This technique is crucial for preventing progression to more severe complications such as cardiac arrest.</span></span></span></span></p>",
      "correct_choice_id": 46811,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54322,
      "choices": [
        {
          "id": 216757,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">FGF </span></span></span></p>"
        },
        {
          "id": 216758,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PDGF </span></span></span></p>"
        },
        {
          "id": 216759,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">TGF alpha </span></span></span></p>"
        },
        {
          "id": 216760,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">TGF beta</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;All of the following are growth promoting proto-oncogenes except?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8852457",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390895,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) TGF beta</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">TGF beta (Transforming Growth Factor beta) is the exception in this list as it is not a growth-promoting proto-oncogene. Instead, TGF beta is a classic example of a tumor suppressor protein. The TGF-beta/SMAD complex acts as a tumor suppressor complex, inhibiting cell growth and promoting apoptosis in normal cells. Loss of function mutations in the TGF-beta pathway can contribute to cancer development by removing this growth-inhibitory signal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. FGF (Fibroblast Growth Factor):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> FGF is indeed a growth-promoting proto-oncogene. It stimulates cell proliferation and survival in various cell types.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. PDGF (Platelet-Derived Growth Factor):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> PDGF is a growth-promoting proto-oncogene. It plays a crucial role in cell growth, division, and blood vessel formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. TGF alpha (Transforming Growth Factor alpha):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> TGF alpha is a growth-promoting proto-oncogene. It stimulates cell proliferation and is often overexpressed in various cancers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among growth factors, TGF beta stands out as a tumor suppressor, while FGF, PDGF, and TGF alpha are growth-promoting proto-oncogenes. Understanding the distinct roles of these factors is crucial in comprehending cancer biology and developing targeted therapies.</span></span></p>",
      "correct_choice_id": 216760,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13795,
      "choices": [
        {
          "id": 55141,
          "text": "<p><span style=\"font-size:12.0pt;\">Index finger</span></p>"
        },
        {
          "id": 55142,
          "text": "<p><span style=\"font-size:12.0pt;\">Little finger</span></p>"
        },
        {
          "id": 55143,
          "text": "<p><span style=\"font-size:12.0pt;\">Middle finger</span></p>"
        },
        {
          "id": 55144,
          "text": "<p><span style=\"font-size:12.0pt;\">Ring finger</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following finger has two dorsal interossei muscles? (AIIMS May 2019)</span></p>",
      "unique_key": "Q2059538",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390896,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Middle finger</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The middle finger has two dorsal interossei muscles flanking it. One is positioned between the index and middle fingers, and the other is positioned between the middle and ring fingers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This anatomical configuration allows the middle finger to be abducted in both directions: towards the index finger and towards the ring finger.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-21.jpg\" alt=\"\" width=\"372\" height=\"435\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The dorsal interossei muscles are four bipennate muscles located between the metacarpal bones in the hand. They are named \"dorsal\" because they are located on the dorsum (back) of the hand, and \"interossei\" means between bones. Their main action is to abduct the fingers away from the axial line, which runs down the center of the third (middle) finger.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A</strong>. <strong>Index finger</strong>: This finger has one dorsal interosseous muscle which abducts the index finger away from the middle finger.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B</strong>. <strong>Little finger</strong>: The little finger also has one dorsal interosseous muscle. This muscle abducts the little finger away from the ring finger.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Ring finger</strong>: The ring finger has one dorsal interosseous muscle which abducts it away from the little finger.</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/08.jpg\" width=\"2224\" height=\"1882\"></p>",
      "correct_choice_id": 55143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9774,
      "choices": [
        {
          "id": 39063,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Auer rod</span></span></span></p>"
        },
        {
          "id": 39064,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Flaming promyelocyte</span></span></span></p>"
        },
        {
          "id": 39065,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Faggot cell</span></span></span></p>"
        },
        {
          "id": 39066,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dusky promyelocyte</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old male patient is diagnosed with acute myeloid leukemia. The peripheral blood smear picture is given in the image. The cell indicated by the arrow is best described as:</span></span> (AIIMS MAY 2019)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/926.jpg\" style=\"height:211px; width:300px\" /></span></span></p>",
      "unique_key": "Q8789298",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390897,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Faggot cell</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The picture shows multiple <strong>Auer rods c</strong>lustered in a single cell resembling a bundle of sticks.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Such cells are called<strong> faggot cells</strong> (faggot meaning bundle of sticks in French). Faggot cells are characteristic of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML) associated with the t(15;17) translocation.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The presence of faggot cells is particularly indicative of APL, where the leukemic promyelocytes have an abundance of Auer rods. Auer rods are distinctive needle-like azurophilic granules formed by the fusion of primary (azurophilic) granules. While Auer rods can be seen in other subtypes of AML, the clustering of these rods within a single cell to form a faggot cell is most commonly associated with APL.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Since the question is particularly about the cell, the best answer from the given options is faggot cell and not Auer rods.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Auer rods</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Auer rods are distinctive needle-like azurophilic granules present in many cases but particularly numerous in <strong>AML with the t(15;17</strong>) aberration (acute promyelocytic leukemia).</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Flaming promyelocyte</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Flaming promyelocyte is an abnormal promyelocyte with disintegrating cytoplasm and liberating Auer rods and granules into the surrounding marrow. Found in APL</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Dusky promyelocyte</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Promyelocytes with fine granules appearing dusky or hazy are called dusky promyelocytes.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A faggot cell, characterized by multiple Auer rods clustered together in a single cell, is highly indicative of acute promyelocytic leukemia (APL). While Auer rods are a feature of various forms of AML, the presence of faggot cells is particularly associated with APL.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbin and Cotrans pathologic basis of disease, 8<sup>th</sup> edition, Pg 1154</span></strong></span></span></p>",
      "correct_choice_id": 39065,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54321,
      "choices": [
        {
          "id": 216753,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amplification </span></span></p>"
        },
        {
          "id": 216754,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion </span></span></p>"
        },
        {
          "id": 216755,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Translocation </span></span></p>"
        },
        {
          "id": 216756,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Point mutation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">FISH can detect all except which of the following?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2498174",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390898,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Point mutation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluorescence in situ hybridization (FISH) is a cytogenetic technique used to detect and localize specific DNA sequences on chromosomes. It can detect chromosomal abnormalities such as amplifications, deletions, and translocations. However, FISH cannot detect point mutations because these are small-scale changes in DNA sequence that occur at the molecular level, not at the chromosomal level that FISH is designed to analyze.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Amplification:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> As FISH can detect gene amplifications, which are increases in the number of copies of a particular gene.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Deletion:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Because FISH can identify chromosomal deletions, where a segment of a chromosome is missing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Translocation:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> As FISH is commonly used to detect chromosomal translocations, where segments of chromosomes have exchanged places.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">FISH (Fluorescence in situ hybridization) can detect chromosomal abnormalities like amplifications, deletions, and translocations, but cannot detect point mutations, which require molecular methods such as PCR for identification.</span></span></span></p>",
      "correct_choice_id": 216756,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7061,
      "choices": [
        {
          "id": 28212,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Labile hypertension</span></span></span></p>"
        },
        {
          "id": 28213,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pulmonary hypertension</span></span></span></p>"
        },
        {
          "id": 28214,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment of resistant migraine</span></span></span></p>"
        },
        {
          "id": 28215,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Resistant Parkinson&#39;s disease</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhaled Nitric oxide is approved for treatment of? (</span></span>INICET May 2021)</p>",
      "unique_key": "Q6194604",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390899,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Pulmonary hypertension</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inhaled Nitric Oxide (NO) has specific clinical applications, particularly in the field of pulmonary medicine. It is approved for the treatment of pulmonary hypertension, especially in certain acute settings. It works by selectively dilating the pulmonary vessels by increasing cyclic guanosine monophosphate (cGMP), thereby reducing pulmonary artery pressure and improving oxygenation. Inhaled nitric oxide is particularly noted for its use in newborns with hypoxic respiratory failure associated with pulmonary hypertension. It can also be used in the acute management of pulmonary hypertension in adults during cardiac surgery or critical care settings.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Labile Hypertension</strong>: Inhaled nitric oxide is not used for the treatment of labile hypertension. Hypertension is typically managed with systemic medications rather than inhaled agents.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Treatment of Resistant Migraine</strong>: Inhaled nitric oxide is not a standard treatment for migraines, whether typical or resistant. Migraine treatment usually involves a range of other pharmacological interventions.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Resistant Parkinson&#39;s Disease</span></strong><span style=\"font-size:12.0pt\">: There is no established role for inhaled nitric oxide in the treatment of Parkinson&rsquo;s disease. Parkinson&#39;s disease management primarily involves medications that affect dopamine pathways.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other uses of inhaled Nitric Oxide:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Neonatal Care</span></strong><span style=\"font-size:12.0pt\">: It is particularly valuable in the treatment of newborns with persistent pulmonary hypertension of the newborn (PPHN) to improve oxygenation.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acute Respiratory Distress Syndrome (ARDS)</span></strong><span style=\"font-size:12.0pt\">: While its benefits in ARDS in adults are still a subject of research and debate, it has been used for its pulmonary vasodilator effects in some critical care settings.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Cardiac Surgery</span></strong><span style=\"font-size:12.0pt\">: Inhaled NO can be used during cardiac surgery to control pulmonary artery pressures.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Lung Transplantation</span></strong><span style=\"font-size:12.0pt\">: It may be used to reduce pulmonary hypertension and improve graft function immediately after transplantation.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inhaled Nitric Oxide is approved for the treatment of pulmonary hypertension, particularly in acute settings to reduce pulmonary artery pressure and improve oxygenation. It is not used for labile hypertension, migraines, or Parkinson&#39;s disease.</span></span></span></p>",
      "correct_choice_id": 28213,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74684,
      "choices": [
        {
          "id": 297649,
          "text": "<p><span style=\"font-size:16px;\">Abdominal pain or discomfort is the commonest presentation for ectopic in 90%</span></p>"
        },
        {
          "id": 297650,
          "text": "<p><span style=\"font-size:16px;\">Oral methotrexate is the choice of medical management in patient with shock</span></p>"
        },
        {
          "id": 297651,
          "text": "<p><span style=\"font-size:16px;\">Ectopic pregnancy is increased in patient with history of PID</span></p>"
        },
        {
          "id": 297652,
          "text": "<p><span style=\"font-size:16px;\">Patient will have reduced levels of progesterone but is not diagnostic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 26-year woman with six weeks of amenorrhea presents with sharp lower abdominal pain, light vaginal spotting and a bp of 90/ 60 mmHg.&nbsp; pelvic exam reveals right adnexal tenderness. Choose the incorrect statement about this condition. (INICET NOV 2024)</span></p>",
      "unique_key": "Q3341274",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390900,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Oral methotrexate is the choice of medical management in patient with shock</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The clinical scenario describes a classic presentation of <strong>ruptured ectopic pregnancy</strong> with the triad of <strong>amenorrhea, pain, and vaginal bleeding</strong>, along with signs of <strong>shock (BP 90/60 mmHg) and adnexal tenderness.&nbsp;</strong>The statement about oral methotrexate is incorrect because:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Methotrexate is given as an intramuscular injection, not orally</strong></span></li><li><span style=\"font-size:16px;\">Medical management is contraindicated in patients with shock; they require <strong>immediate surgical intervention</strong></span></li><li><span style=\"font-size:16px;\">Hemodynamic instability is an <strong>absolute contraindication</strong> to medical management</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Abdominal pain or discomfort is the commonest presentation for ectopic in 90%:&nbsp;</strong>Pain is indeed the most common presenting symptom of ectopic pregnancy, occurring in approximately 90% of cases. The clinical triad includes pain, amenorrhea, and vaginal bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Ectopic pregnancy is increased in patient with history of PID:&nbsp;</strong>PID increases the risk of ectopic pregnancy by <strong>causing salpingitis</strong>, which reduces tubal motility and can lead to implantation within the fallopian tube.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Patient will have reduced levels of progesterone but is not diagnostic:&nbsp;</strong>While progesterone levels are typically lower in ectopic pregnancy compared to normal intrauterine pregnancy, this finding is not diagnostic and is not used for clinical decision-making.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Medical management with methotrexate is contraindicated in ectopic pregnancy with hemodynamic instability (shock); such cases require <strong>immediate surgical intervention</strong>.</span></p>",
      "correct_choice_id": 297650,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 63329,
      "choices": [
        {
          "id": 252533,
          "text": "<p><span style=\"font-size:12.0pt;\">c, b, a, d</span></p>"
        },
        {
          "id": 252534,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c, d</span></p>"
        },
        {
          "id": 252535,
          "text": "<p><span style=\"font-size:12.0pt;\">a, c, b, d</span></p>"
        },
        {
          "id": 252536,
          "text": "<p><span style=\"font-size:12.0pt;\">b, c, a, d</span></p>"
        }
      ],
      "text": "<p>Arrange the sequence of steps in leukocyte migration:&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">a. Stable adhesion</span><br><span style=\"font-size:12.0pt;\">b. Integration activation by chemokine</span><br><span style=\"font-size:12.0pt;\">c. Rolling</span><br><span style=\"font-size:12.0pt;\">d. Migration through endothelium</span></p>",
      "unique_key": "Q8433242",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390901,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) c, b, a, d</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Leukocyte migration from the bloodstream to the tissue during inflammation is a multi-step process:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Rolling (c)</strong>: Leukocytes first \"roll\" along the endothelium. This process is mediated by selectins, which interact with glycoproteins on the leukocyte surface. Rolling allows leukocytes to slow down and move along the vessel wall.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Activation by chemokines (b)</strong>: Chemokines activate integrins on leukocytes, increasing their affinity for adhesion molecules on the endothelial surface.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stable adhesion (a)</strong>: Once integrins are activated, leukocytes firmly adhere to the endothelium through integrin-mediated binding.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Migration through endothelium (d)</strong>: Finally, leukocytes migrate across the endothelial barrier into the tissue through a process called diapedesis, following a chemotactic gradient to the site of inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-05%20150410.jpg\" width=\"1251\" height=\"615\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Leukocyte migration involves rolling, chemokine-mediated integrin activation, stable adhesion, and migration across the endothelium, a crucial sequence in the immune response during inflammation.</span></p>",
      "correct_choice_id": 252533,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74912,
      "choices": [
        {
          "id": 298545,
          "text": "<p><span style=\"font-size:16px;\">1, 3</span></p>"
        },
        {
          "id": 298546,
          "text": "<p><span style=\"font-size:16px;\">1, 4</span></p>"
        },
        {
          "id": 298547,
          "text": "<p><span style=\"font-size:16px;\">2, 3</span></p>"
        },
        {
          "id": 298548,
          "text": "<p><span style=\"font-size:16px;\">1, 2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">In haemolytic anaemia, which of the following is correct? (INICET NOV 2024)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Urobilinogen is high</span></li><li><span style=\"font-size:16px;\">Serum conjugated bilirubin is elevated</span></li><li><span style=\"font-size:16px;\">Serum transaminases are increased</span></li><li><span style=\"font-size:16px;\">Indirect van den Bergh reaction is positive</span></li></ol>",
      "unique_key": "Q9460911",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390902,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) 1, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In haemolytic anaemia, there is increased destruction of red blood cells leading to elevated <strong>unconjugated (indirect) bilirubin</strong>. This results in:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>1. Urobilinogen is high:</strong> Increased <strong>urobilinogen</strong> in urine due to normal enterohepatic circulation</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>4. Indirect van den Bergh reaction is positive:&nbsp;</strong>Positive indirect van den Bergh reaction due to elevated unconjugated bilirubin</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">These findings are characteristic of haemolytic anaemia and help differentiate it from other causes of jaundice.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>2. Serum conjugated bilirubin is elevated:</strong> Incorrect, as conjugated bilirubin elevation is typically seen in obstructive jaundice or hepatic diseases, not in haemolytic anaemia</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>3. Serum transaminases are increased:</strong> Incorrect, as elevated transaminases indicate liver cell damage, which is not a feature of haemolytic anaemia</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Haemolytic anaemia is characterized by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Increased urobilinogen in urine</span></li><li><span style=\"font-size:16px;\">Elevated unconjugated (indirect) bilirubin</span></li><li><span style=\"font-size:16px;\">Positive indirect van den Bergh reaction</span></li><li><span style=\"font-size:16px;\">Normal enterohepatic circulation</span></li></ul>",
      "correct_choice_id": 298546,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74912/INI-CET_NOV_2024_Medicine_Q_-_37.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74912/INI-CET_NOV_2024_Medicine_Q_-_37.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10347,
      "choices": [
        {
          "id": 41354,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased pulmonary blood flow</span></p>"
        },
        {
          "id": 41355,
          "text": "<p><span style=\"font-size:12.0pt;\">Narrow vascular pedicle</span></p>"
        },
        {
          "id": 41356,
          "text": "<p><span style=\"font-size:12.0pt;\">Right atrial enlargement</span></p>"
        },
        {
          "id": 41357,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary venous hypertension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following, all are findings of the condition in the below chest X-ray except: (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/98.jpg\" alt=\"\" width=\"300\" height=\"256\"></span></p>",
      "unique_key": "Q9248054",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390903,
      "difficulty_level": "difficult",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Pulmonary venous hypertension</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The chest X-ray provided shows the characteristic \"egg-on-a-string\" appearance, which is indicative of Transposition of the Great Arteries (TGA). In TGA, the aorta arises from the right ventricle and the pulmonary artery arises from the left ventricle, leading to parallel circulation. This is a severe congenital heart defect that requires immediate attention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In TGA, the following findings are seen:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Right atrial enlargement:</strong> This occurs due to increased venous return to the right side of the heart, as blood from the body is directed to the right atrium and ventricle, which then pumps it to the aorta and systemic circulation. This enlargement is visible on the X-ray.</span></li><li><span style=\"font-size:12pt;\"><strong>Narrow vascular pedicle:</strong> The \"string\" appearance of the mediastinum is due to a narrow vascular pedicle, which is a common radiographic finding in TGA. This narrowness results from the abnormal positioning and arrangement of the great arteries.</span></li><li><span style=\"font-size:12pt;\"><strong>Increased pulmonary blood flow:</strong> Depending on the presence and size of any associated shunts (like a patent ductus arteriosus or a ventricular septal defect), there can be increased pulmonary blood flow, which is often observed in cases of TGA.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">However, <strong>pulmonary venous hypertension</strong> is <strong>not</strong> a typical finding in TGA. Pulmonary venous hypertension is usually seen in conditions that increase pressure in the pulmonary veins, such as left heart failure or mitral valve disease. It is not characteristic of TGA, where the primary issue is with the arteries and not the pulmonary veins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Increased pulmonary blood flow:</strong> This can occur in TGA, especially if there is a shunt allowing some oxygenated blood to reach the systemic circulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Narrow vascular pedicle:</strong> The \"string\" part of the \"egg-on-a-string\" appearance refers to the narrow mediastinum, which is due to the narrow vascular pedicle, a common finding in TGA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Right atrial enlargement:</strong> Right atrial enlargement: Enlargement of the right atrium is seen in TGA due to the abnormal circulation pattern but is a rare feature.</span><br><span style=\"font-size:12pt;\">Both atria can enlarge in TGA, but left predominates</span><br><span style=\"font-size:12pt;\">With mixing lesions (VSD, ASD), right atrial enlargement can happen</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The \"egg-on-a-string\" appearance on a chest X-ray is characteristic of Transposition of the Great Arteries (TGA), and pulmonary venous hypertension is not a typical finding in this condition.</span></p>",
      "correct_choice_id": 41357,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74693,
      "choices": [
        {
          "id": 297685,
          "text": "<p><span style=\"font-size:16px;\">Vigorous term babies not requiring resuscitation</span></p>"
        },
        {
          "id": 297686,
          "text": "<p><span style=\"font-size:16px;\">All preterm babies irrespective of birth weight</span></p>"
        },
        {
          "id": 297687,
          "text": "<p><span style=\"font-size:16px;\">Vigorous term and preterm babies not requiring resuscitation</span></p>"
        },
        {
          "id": 297688,
          "text": "<p><span style=\"font-size:16px;\">All term babies irrespective of birth weight</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">When is delayed cord clamping done? (INICET NOV 2024)</span></p>",
      "unique_key": "Q1900621",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390904,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Vigorous term and preterm babies not requiring resuscitation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">According to WHO guidelines, delayed cord clamping should be performed in all vigorous term and preterm babies <strong>who do not require resuscitation</strong>. This practice has been incorporated into the <strong>active management of third stage of labor (AMTSL) protocol</strong>. The primary benefit is the prevention of neonatal anemia, with particular effectiveness in preterm infants.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Vigorous term babies not requiring resuscitation:&nbsp;</strong>Incorrect because it excludes preterm babies, who benefit more from delayed cord clamping</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. All preterm babies irrespective of birth weight:&nbsp;</strong>Incorrect because it includes preterm babies requiring resuscitation, which is a contraindication for delayed cord clamping</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. All term babies irrespective of birth weight:&nbsp;</strong>Incorrect because it includes babies requiring resuscitation, which is a contraindication for delayed cord clamping</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Delayed cord clamping should be performed in all vigorous term and preterm babies not requiring resuscitation, with the only contraindication being the need for immediate resuscitation in an asphyxiated baby.</span></p>",
      "correct_choice_id": 297687,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10073,
      "choices": [
        {
          "id": 40258,
          "text": "<p><span style=\"font-size:12.0pt;\">WASP gene mutation</span></p>"
        },
        {
          "id": 40259,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-platelet antibodies</span></p>"
        },
        {
          "id": 40260,
          "text": "<p><span style=\"font-size:12.0pt;\">Bone marrow biopsy</span></p>"
        },
        {
          "id": 40261,
          "text": "<p><span style=\"font-size:12.0pt;\">Electron microscopy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 15-year-old boy presents to the Pediatrics OPD with the complaints of several episodes of melena. On physical examination, there was eczematous rash over the skin with multiple red pin-point hemorrhagic spots. His Hemogram reveals low platelet count and normal RBC and WBC counts. What is the next best investigation?&nbsp;(INICET MAY 2022)</span></p>",
      "unique_key": "Q5726206",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390905,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) WASP gene mutation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical symptoms of the patient (recurrent Melena, eczema and red pin-point hemorrhagic spots) are pointing towards the diagnosis of Wiskott-Aldrich Syndrome. It occurs due to WASP gene mutation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">So Next best step would be to analyze for WASP mutation (Chromosome Xp).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Wiskott-Aldrich syndrome is an X-linked recessive immunodeficiency disorder characterized by –</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Thrombocytopenia</span></li><li><span style=\"font-size:12.0pt;\">Recurrent bleeding (Melena, Epistaxis or Hematemesis)</span></li><li><span style=\"font-size:12.0pt;\">Low Immunity, Recurrent Infections, Eczema</span></li><li><span style=\"font-size:12.0pt;\">Low IgM and high IgA &amp; IgE</span></li><li><span style=\"font-size:12.0pt;\">Normal thymus but reduced T-cells in blood</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The only treatment for this condition is Bone Marrow Transplantation.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture6.jpg\" alt=\"\" width=\"500\" height=\"242\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anti-platelet antibodies</strong>: While these are relevant in conditions like immune thrombocytopenia (ITP), they are not the primary investigation for Wiskott-Aldrich Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Bone marrow biopsy</strong>: This can be used to assess marrow function but is not specific for diagnosing Wiskott-Aldrich Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Electron microscopy</strong>: Although useful in some hematological disorders, it is not the first-line diagnostic tool for Wiskott-Aldrich Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Wiskott-Aldrich Syndrome should be suspected in a pediatric patient with thrombocytopenia, eczema, and recurrent bleeding episodes, and the next best step is to investigate for a WASP gene mutation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease 8th edition pg 439-440</strong></span></p>",
      "correct_choice_id": 40258,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9770,
      "choices": [
        {
          "id": 39047,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Philadelphia chromosome</span></span></span></p>"
        },
        {
          "id": 39048,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">JAK mutation</span></span></span></p>"
        },
        {
          "id": 39049,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythropoietin levels</span></span></span></p>"
        },
        {
          "id": 39050,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bone Marrow biopsy with reticulin stain</span></span></span></p>"
        }
      ],
      "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A young boy from high altitude came with fever and weakness and had the following reports Hemoglobin 17 gm%, TLC is 21,000 with neutrophils 25, lymphocytes 30, eosinophils 5, myelocytes and metamyelocytes 40 in peripheral smear. Next step in the investigation should be:&nbsp;</span></span></span>(AIIMS MAY 2019)</p>",
      "unique_key": "Q3753095",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390906,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Erythropoietin levels</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The given clinical scenario is suggestive of polycythemia (Hb&gt;16 g/dL). Erythropoietin levels should be determined to differentiate primary from secondary forms.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Polycythemia vera (PCV) is characterized by increased marrow production of red cells, granulocytes, and platelets (panmyelosis), but it is the increase in red cells (polycythemia), that is responsible for most of the clinical symptoms. PCV must be differentiated from relative polycythemia resulting from hemoconcentration and other causes of absolute polycythemia. PCV is strongly associated with activating point mutations in the tyrosine kinase JAK2.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In PCV the progenitor cells have markedly decreased requirements for erythropoietin and other hematopoietic growth factors due to constitutive JAK2 signaling. Accordingly, serum erythropoietin levels in PCV are very low, whereas secondary forms of absolute polycythemia have high erythropoietin levels.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-113555.png\" style=\"height:613px; width:1000px\" /></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Philadelphia chromosome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This test is relevant in diagnosing chronic myeloid leukemia (CML), not polycythemia. While the presence of immature myeloid cells (myelocytes and metamyelocytes) could suggest a myeloproliferative disorder, the patient&#39;s clinical presentation and high hemoglobin level are more consistent with polycythemia, making erythropoietin testing a more appropriate next step.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. JAK mutation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Testing for the JAK2 mutation is crucial in confirming a diagnosis of PCV. However, before proceeding to this test, it is important to measure erythropoietin levels to differentiate between primary and secondary polycythemia. If erythropoietin levels are low, JAK2 mutation analysis would then be the next step.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Bone Marrow biopsy with reticulin stain</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This investigation is used to evaluate bone marrow fibrosis, which can occur in myeloproliferative disorders like PCV. However, it is not the first-line investigation in this scenario. The erythropoietin level is a less invasive test that provides critical information to guide further diagnostic steps.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erythropoietin levels should be measured to differentiate between primary and secondary polycythemia. In cases of polycythemia vera, erythropoietin levels are typically low due to constitutive JAK2 signaling, while secondary polycythemia is associated with high erythropoietin levels.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Robbins and Cortans pathologic basis of disease, Pg 1161, 1242</span></strong></span></span></p>",
      "correct_choice_id": 39049,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 577,
      "choices": [
        {
          "id": 2304,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEV1 &lt; 0.85 and FEV1/FVC &lt;0.8</span></span></span></p>"
        },
        {
          "id": 2305,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEV1 &lt; 0.85 and FEV1/FVC &lt;0.75</span></span></span></p>"
        },
        {
          "id": 2306,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEV1 &lt; 0.8 and FEV1/FVC &lt;0.7</span></span></span></p>"
        },
        {
          "id": 2307,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEV1 &lt; 0.8 and FEV1/FVC &lt;0.75</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old male patient has grade III ASA. Which of the following post bronchodilator PFT findings requires further evaluation of the lung function of the patient? (</span></span></span>INICET Nov 2021)</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ASA- American Society of Anesthesiology</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PFT- Pulmonary function test</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEV1 - Forced expiratory volume in 1 second</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FVC- Forced vital capacity</span></span></span></p>",
      "unique_key": "Q4715111",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390907,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. FEV1 &lt; 0.8 and FEV1/FVC &lt;0.7</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option shows a significant reduction in both FEV1 and the FEV1/FVC ratio. An FEV1/FVC ratio of less than 0.7 is a clear indicator of obstructive lung disease. Combined with the reduced FEV1, this suggests significant lung dysfunction that requires further evaluation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. FEV1 &lt; 0.85 and FEV1/FVC &lt;0.8:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While these values indicate some reduction in lung function, they do not meet the threshold for a definitive diagnosis of obstructive lung disease. The FEV1/FVC ratio is still above the critical cutoff of 0.7.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. FEV1 &lt; 0.85 and FEV1/FVC &lt;0.75:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> These values suggest reduced lung function but not to the extent that is indicative of moderate or severe COPD. The FEV1/FVC ratio is below 0.8 but not yet at the critical threshold of 0.7.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. FEV1 &lt; 0.8 and FEV1/FVC &lt;0.75:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While the FEV1 is below 0.8, the FEV1/FVC ratio is not at the critical threshold of 0.7, so it does not indicate significant obstructive lung disease requiring further evaluation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective :</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As per GOLD criteria for COPD, FEV1 &lt;0.8 and FEV1/FVC &lt;0.7 are classified as moderate COPD and require further evaluation of lung function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GOLD criteria for COPD is given as follows:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/06/screenshot-2024-07-06-150644.jpg\" style=\"height:282px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abbreviations</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: COPD, chronic obstructive pulmonary disease; GOLD, Global Initiative for Lung Disease </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As per GOLD criteria for COPD, FEV1 &lt;0.8 and FEV1/FVC &lt;0.7 are classified as moderate COPD and require further evaluation of the lung function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Miller&rsquo;s Anesthesia, 9<sup>th</sup> Ed. Pg</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>950</strong></span></span></p>",
      "correct_choice_id": 2306,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49024,
      "choices": [
        {
          "id": 195671,
          "text": "<p><span style=\"font-size:18px;\">Start examining</span></p>"
        },
        {
          "id": 195672,
          "text": "<p><span style=\"font-size:18px;\">Inform police</span></p>"
        },
        {
          "id": 195673,
          "text": "<p><span style=\"font-size:18px;\">Preserve clothes</span></p>"
        },
        {
          "id": 195674,
          "text": "<p><span style=\"font-size:18px;\">Get consent from mother for P/V</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A 13-year-old girl presents to you with her mother, reporting abdominal discomfort and is found to be 12 weeks pregnant based on a positive urine pregnancy test. As a medical professional, what would be your initial course of action? </strong><i><strong>[INICET NOV 2023]</strong></i></span></p>",
      "unique_key": "Q7499971",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390908,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Inform Police</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In many jurisdictions, pregnancy in a minor may be considered evidence of statutory rape or sexual abuse, hence, informing the police is crucial for legal proceedings and safeguarding the minor.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Option</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Start examining:&nbsp;</strong>Although a medical examination is necessary, it must be conducted with proper legal and parental consent, especially considering the age and the situation's sensitivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Preserve clothing:&nbsp;</strong>This could be necessary in a case where forensic evidence needs to be gathered, especially if there was recent assault. However, this would follow legal reporting.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Take consent from mother:&nbsp;</strong>Consent is crucial, especially for minors. However, it does not preclude the obligation to report statutory rape or sexual abuse to authorities.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational objective :</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">When dealing with potentially criminal situations involving minors, such as a young teenager's pregnancy, the first step is to ensure the situation is addressed legally and safely.&nbsp;</span></li><li><span style=\"font-size:18px;\">Informing law enforcement and ensuring proper medical and legal procedures safeguard the minor's health and legal rights.</span></li></ul>",
      "correct_choice_id": 195672,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/49024/INI-CET_Nove_2023_PSM_Q_-_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/49024/INI-CET_Nove_2023_PSM_Q_-_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24847,
      "choices": [
        {
          "id": 99349,
          "text": "<p><span style=\"font-size:12.0pt;\">Concha bullosa</span></p>"
        },
        {
          "id": 99350,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumatised superior turbinate</span></p>"
        },
        {
          "id": 99351,
          "text": "<p><span style=\"font-size:12.0pt;\">Onodi cell</span></p>"
        },
        {
          "id": 99352,
          "text": "<p><span style=\"font-size:12.0pt;\">Haller cell</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the marked structure in the given CT image. (INICET NOVEMBER 2021)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-094423.png\" alt=\"\" width=\"400\" height=\"301\"></p>",
      "unique_key": "Q9956506",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390909,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Pneumatised superior turbinate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The&nbsp;superior turbinates&nbsp;form one of the three pairs of&nbsp;conchae&nbsp;in the&nbsp;nose&nbsp;and represent part of the&nbsp;labyrinth of the ethmoid bone, arising as bony projections from its posterior surface.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The air passage between the superior nasal concha and the lateral nasal wall is known as the&nbsp;superior meatus&nbsp;and forms part of the&nbsp;nasal cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Concha bullosa</strong> is a pneumatized middle turbinate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/picture48.jpg\" alt=\"\" width=\"300\" height=\"257\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Onodi cell</strong>/ Sphenoethmoidal air cell is the posterior most&nbsp;ethmoidal air cell.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/picture49.jpg\" alt=\"\" width=\"300\" height=\"328\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Haller cell/</strong> infraorbital ethmoidal air cells are ethmoid air cells located lateral to the maxillo-ethmoidal suture along the inferomedial orbital floor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/picture50.jpg\" alt=\"\" width=\"300\" height=\"226\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pneumatisation of the superior turbinate, indicates the presence of air spaces within the turbinates, which can have implications for nasal physiology and potential sinus pathologies.</span></p>",
      "correct_choice_id": 99350,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6721,
      "choices": [
        {
          "id": 26853,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">20-25 Hz</span></span></p>"
        },
        {
          "id": 26854,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">30-35 Hz</span></span></p>"
        },
        {
          "id": 26855,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">15-20 Hz</span></span></p>"
        },
        {
          "id": 26856,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">10-15 Hz</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given below is the demonstration of tetanisation in the gastrocnemius muscle of a frog. Identify the tetanising frequency? (</span></span>AIIMS May 2017)</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-165727_Gis8eaW.png\" style=\"height:351px; width:400px\" /></span></span></p>",
      "unique_key": "Q1288844",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390910,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) 20-25 Hz</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tetanizing frequency demonstrated by the muscle is 25Hz.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tetanizing frequency: Rate of stimulation at which summation of contractions will occur</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tetanizing frequency can be calculated as </span><span style=\"font-size:12.0pt\"><span style=\"font-family:Wingdings\">&agrave;</span></span><span style=\"font-size:12.0pt\"> <strong>1/contraction period.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">As per the graph - </span></span></span></p>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿Paper speed - 1000mm/sec.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿y-axis represents force of muscle contraction millivolts</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">x-axis represents duration of contraction in milliseconds with a scale of 10mm</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿The scale on the x-axis is 10mm.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿Area under the graph is the muscle contraction.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Contraction period the duration from latent period to maximum force of contraction</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">So, in the given graph, </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Contraction period is approximately 4 scales i.e., 40 mm.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">As the speed of the paper is 1000mm/sec, contraction period = 40mm = (40/1000) = 40 msec = 0.04sec</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tetanizing frequency = 1/contraction period = 1/0.04 = 100/4 = 25Hz.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Tetanisation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As the frequency increases, there comes a point where each new contraction occurs before the preceding one is over. As a result, the second contraction is added partially to the first, so that the total strength of contraction rises progressively with increasing frequency. When the frequency reaches a critical level, the successive contractions eventually become so rapid that they fuse together, and the whole muscle contraction appears to be completely smooth and continuous. This is called tetanization.&nbsp; </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-165901.png\" style=\"height:407px; width:500px\" /></span></span></p>",
      "correct_choice_id": 26853,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10236,
      "choices": [
        {
          "id": 40910,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-b, 2-c, 3-d, 4-a</span></span></span></p>"
        },
        {
          "id": 40911,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-a, 2-b, 3-d, 4-c</span></span></span></p>"
        },
        {
          "id": 40912,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-d, 2-c, 3-a, 4-b</span></span></span></p>"
        },
        {
          "id": 40913,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-c, 2-b, 3-d, 4-a</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following scale types with their lesions?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13558_1YHi2Nx.jpg\" style=\"height:200px; width:800px\" /></span></span></p>",
      "unique_key": "Q3481811",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390911,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1-b, 2-c, 3-d, 4-a</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Matched Pairs:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><strong><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">1-b: Collarette scales - Pityriasis Rosea:</span>&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Collarette scales are characteristic of Pityriasis Rosea, where these scales are fine, peripherally attached but centrally detached, often found around the edge of the herald patch or subsequent lesions.</span></span></span></li>\r\n\t<li><strong><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">2-c: Silvery scales - Psoriasis</span>:&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Silvery scales are hallmark features of Psoriasis. These scales are typically seen as thick, shiny, and silvery white, indicative of excessive proliferation of skin layers, particularly due to parakeratosis.</span></span></span></li>\r\n\t<li><strong><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">3-d: Mica-like scales - Pityriasis lichenoides chronica:</span>&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mica-like scales in Pityriasis lichenoides chronica refer to the fine, adherent scales that resemble mineral mica, found on polymorphic lesions that can also show hemorrhagic crusting.</span></span></span></li>\r\n\t<li><strong><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">4-a: Branny scales - Pityriasis versicolor</span>:&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Branny scales are a feature of Pityriasis versicolor, described as fine, powdery, and often easily detachable, much like bran. These scales highlight the superficial fungal infection&#39;s impact on the skin.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture8.jpg\" style=\"height:177px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture9_6tWtHra.jpg\" style=\"height:229px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture10.jpg\" style=\"height:271px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture11.jpg\" style=\"height:249px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture12_BOpEZzo.jpg\" style=\"height:205px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture14.jpg\" style=\"height:253px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture15.jpg\" style=\"height:232px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diseases &amp; special scales:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-181649.png\" style=\"height:445px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref - Rook&#39;s Textbook of Dermatology -9th Edition Chapter 28 Page no 4.13, 26.2, 29.15, 40.1-40.5, 50.6, 65.2, 107.3, 109.8</span></strong></span></span></p>",
      "correct_choice_id": 40910,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13779,
      "choices": [
        {
          "id": 55077,
          "text": "<p><span style=\"font-size:12.0pt;\">Caudate nucleus</span></p>"
        },
        {
          "id": 55078,
          "text": "<p><span style=\"font-size:12.0pt;\">Lentiform nucleus</span></p>"
        },
        {
          "id": 55079,
          "text": "<p><span style=\"font-size:12.0pt;\">Dentate nucleus</span></p>"
        },
        {
          "id": 55080,
          "text": "<p><span style=\"font-size:12.0pt;\">Red nucleus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Purkinje cells of cerebellum relay into: (</span>AIIMS May 2018)</p>",
      "unique_key": "Q1986463",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390912,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Dentate nucleus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cerebellum's purkinje cells relay information to the dentate nucleus, one of the deep cerebellar nuclei.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is the cerebellum's distinguishing cell. It is a large flask-shaped cell. Climbing fibres from the inferior olivary nucleus stimulate it. This cell's main output is inhibitory in nature and is directed at cerebellar nuclei. These are the most important output neurons.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-12.jpg\" alt=\"\" width=\"500\" height=\"280\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Caudate Nucleus</strong>: It's one of the structures that make up the basal ganglia in the brain. The caudate nucleus has a long, C-shaped structure and is located laterally in the brain, near the lateral ventricles. It plays roles in various functions like voluntary movement control, learning, memory, and emotion. Purkinje cells do not primarily relay into the caudate nucleus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Lentiform Nucleus</strong>: Another component of the basal ganglia, the lentiform nucleus is located deep within the brain and is laterally placed in relation to the thalamus. The lentiform nucleus is made up of two structures: the putamen and the globus pallidus. It's involved in movement regulation and other functions. Purkinje cells do not have a direct relay into the lentiform nucleus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Red Nucleus</strong>: Found in the midbrain, the red nucleus has a reddish hue due to its rich blood supply and the presence of iron. It plays a role in motor coordination, particularly in the coordination of limb movements. While the red nucleus does receive input from the cerebellum, the primary relay from Purkinje cells is to the deep cerebellar nuclei, not directly to the red nucleus. The dentate nucleus, in turn, can send projections to the red nucleus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Dentate Nucleus</strong> is one of the deep cerebellar nuclei and is situated within the white matter of the cerebellum. The dentate nucleus is the largest of the deep cerebellar nuclei and plays a role in the planning, initiation, and control of voluntary movements.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Purkinje cells in the cerebellar cortex send inhibitory projections to the deep cerebellar nuclei, including the dentate nucleus. This is the main output pathway for the cerebellar cortex.</span></p>",
      "correct_choice_id": 55079,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10046,
      "choices": [
        {
          "id": 40150,
          "text": "<p><span style=\"font-size:12.0pt;\">Megaloblastic anemia</span></p>"
        },
        {
          "id": 40151,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron-deficiency anemia</span></p>"
        },
        {
          "id": 40152,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia major</span></p>"
        },
        {
          "id": 40153,
          "text": "<p><span style=\"font-size:12.0pt;\">Essential thrombocytosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\">A 35-year-old woman presented in OPD with complaints of fatigue and weakness. Investigations revealed the following as shown below. The peripheral smear is shown below. What is the diagnosis? (INICET NOV 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hb – 5 g%</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MCH – 24</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MCV – Low</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">TLC – 11000 /µL</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Platelets – 5,00,000 /cubic mm</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Normal values:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Mean cell volume (MCV): 90 +/- 8 fL</span></li><li><span style=\"font-size:12.0pt;\">Mean cell Hb (MCH): 30 +/- 3 pg</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture11.jpg\" alt=\"\" width=\"300\" height=\"216\"></span></p>",
      "unique_key": "Q7325166",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390913,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Iron-deficiency anemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical scenario is suggestive of microcytic hypochromic anemia for which the most common cause is Iron Deficiency Anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Iron deficiency anemia is characterized by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Low serum ferritin</strong>: Reflects low iron stores.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Low serum iron</strong>: Indicates a lack of available iron.</span></li><li><span style=\"font-size:12.0pt;\"><strong>High TIBC (Total Iron Binding Capacity)</strong>: Reflects the body’s increased capacity to bind iron, which happens when iron levels are low.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Low transferrin saturation</strong>: Reflects low iron availability relative to the binding capacity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These findings together with the low MCV, low MCH, low Hb and compensatory increase in the platelets strongly suggest iron deficiency anemia rather than other conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Megaloblastic anemia</strong>: Typically presents with macrocytic anemia (high MCV), which is not the case here. Also, MCH would generally be elevated in megaloblastic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Thalassemia major</strong>: This condition would also present with microcytic anemia, but it typically does not show such severe hypochromia or the thrombocytosis seen in this case. Additionally, the Mentzer index (MCV/RBC count) is typically less than 13 in thalassemia trait, not in severe iron deficiency anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Essential thrombocytosis</strong>: While this condition does present with an elevated platelet count, it does not typically present with the microcytic, hypochromic anemia seen in iron deficiency anemia. The primary abnormality in essential thrombocytosis is the elevated platelet count, without the severe anemia observed here.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-171012.png\" alt=\"\" width=\"500\" height=\"415\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-171054.png\" alt=\"\" width=\"1000\" height=\"328\"></p>",
      "correct_choice_id": 40151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50953,
      "choices": [
        {
          "id": 203353,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute HBV infection in window period&nbsp;</span></p>"
        },
        {
          "id": 203354,
          "text": "<p><span style=\"font-size:12.0pt;\">Immune with recombinant HBV Vaccine&nbsp;</span></p>"
        },
        {
          "id": 203355,
          "text": "<p><span style=\"font-size:12.0pt;\">HBV infection in the remote past, completely recovered&nbsp;</span></p>"
        },
        {
          "id": 203356,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic HBV infection inactive carrier&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The blood investigation of a patient is given below. What is the probable diagnosis? (</span>INICET Nov 2023)</p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">HBsAg - NR,</span></li><li><span style=\"font-size:12.0pt;\">Anti HBs - NR,</span></li><li><span style=\"font-size:12.0pt;\">Anti HBc IgM - NR,</span></li><li><span style=\"font-size:12.0pt;\">Anti HBc total - positive,</span></li><li><span style=\"font-size:12.0pt;\">HBeAg - NR,</span></li><li><span style=\"font-size:12.0pt;\">Anti HBe – NR (NR – Non reactive)</span></li></ul>",
      "unique_key": "Q1615461",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390914,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;C) HBV infection in the remote past, completely recovered</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's serological markers indicate the following:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">HBsAg - Non-Reactive (NR): This suggests that the patient is not currently infected with Hepatitis B.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anti HBs - NR: Lack of antibodies against the Hepatitis B surface antigen suggests no current immunity from vaccination or recent infection.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anti HBc IgM - NR: The absence of IgM antibodies against the core antigen indicates no recent acute infection.</span></li><li><span style=\"font-size:12.0pt;\">Anti HBc total - positive: Presence of total core antibodies (including IgG) indicates past exposure to the virus.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">HBeAg - NR: Absence of the e antigen suggests no active viral replication.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anti HBe - NR: Absence of antibodies against the e antigen suggests no current or recent active infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given these markers, the most likely scenario is that the patient had a Hepatitis B infection in the past and has completely recovered. The presence of Anti HBc total (which is predominantly IgG) signifies past infection. In cases of remote past infection, anti-HBs antibodies may fall below detectable levels, although the patient still has immunity through memory B cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acute HBV infection in window period:&nbsp;</strong>In the window period of acute HBV infection, Anti HBc IgM should be positive, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Immune with recombinant HBV Vaccine:&nbsp;</strong>Patients vaccinated against HBV typically have positive Anti HBs and negative Anti HBc total, as they have not been exposed to the virus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chronic HBV infection inactive carrier:</strong>&nbsp;Chronic HBV infection requires the presence of HBsAg for more than six months. The absence of HBsAg rules out chronic infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of Anti HBc total (predominantly IgG) with all other markers negative suggests a past HBV infection that has completely resolved.</span></p>",
      "correct_choice_id": 203355,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9950,
      "choices": [
        {
          "id": 39766,
          "text": "<p><span style=\"font-size:12pt;\">HPV</span></p>"
        },
        {
          "id": 39767,
          "text": "<p><span style=\"font-size:12pt;\">Pox virus</span></p>"
        },
        {
          "id": 39768,
          "text": "<p><span style=\"font-size:12pt;\">Adenovirus</span></p>"
        },
        {
          "id": 39769,
          "text": "<p><span style=\"font-size:12pt;\">Herpes virus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The presence of a pearly white papule on the mother's forehead, which is also seen in her infant, can be due to which of the following virus? (</span>AIIMS Nov 2018)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13537.jpg\" alt=\"\" width=\"300\" height=\"245\"></span></p><p>&nbsp;</p>",
      "unique_key": "Q7437974",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390915,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Pox virus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The above image shows shiny, pearly white, umbilicated papules which are suggestive of molluscum contagiosum. <strong>It’s a DNA virus</strong>.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It is mainly caused by Pox virus which is a DNA virus.</span></li><li><span style=\"font-size:12pt;\"><strong>Virus:&nbsp;</strong>Molluscum Contagiosum Virus (MCV).</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>MCV-1:</strong> Children over Face (Not seen over palms &amp; soles).</span></li><li><span style=\"font-size:12pt;\"><strong>MCV-2:</strong> Adults producing lesions over Genitals.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Microscopic examination -&nbsp;</strong>Lesions shows eosinophilic inclusions called <strong>Henderson-Patterson bodies.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Transmission:&nbsp;</strong>Skin to skin contact.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Note:&nbsp;</strong>Sexually transmitted molluscum contagiosum may be present over the genital area.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Treatment:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Usually, it is <strong>self-limiting</strong> and will disappear by itself. Thus, there is no need for treatment.</span></li><li><span style=\"font-size:12pt;\">Destruction with <strong>cantharidin, trichloroacetic acid, diluted liquefied phenol, or surgical removal</strong> are a few options.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Pseudo-Koebner phenomenon:&nbsp;</strong>New lesions develop along the line of trauma due to Autoinoculation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;<strong>HPV (Human Papilloma Virus)&nbsp;</strong>leads to <strong>warts</strong>, but the lesions are typically <strong>rough-surfaced as shown in the image below, </strong>rather than pearly.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture27.jpg\" alt=\"\" width=\"400\" height=\"267\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;<strong>Adenovirus&nbsp;</strong>does not typically cause visible skin manifestations like the one shown.</span></li><li><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Herpes virus&nbsp;</strong>causes <strong>vesicular</strong> and <strong>ulcerative</strong> lesions as shown in the image below, rather than pearly papules.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture28.jpg\" alt=\"\" width=\"400\" height=\"312\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The presence of <strong>pearly white papules</strong> in both a <strong>mother</strong> and her <strong>infant</strong> is indicative of <strong>molluscum contagiosum</strong>, a skin infection caused by a <strong>Poxvirus.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rook's Textbook of Dermatology - 9th Edition - Volume I, Chapter 25, Page no 25.12-14</strong></span></p>",
      "correct_choice_id": 39767,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30725,
      "choices": [
        {
          "id": 122778,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">1-A, 2-B, 3-C, 4-D</span></span></span></span></p>"
        },
        {
          "id": 122779,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">1-D, 2-F, 3-E, 4-C</span></span></span></span></p>"
        },
        {
          "id": 122780,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">1-D, 2-A, 3-C 4-E</span></span></span></span></p>"
        },
        {
          "id": 122781,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">1-D, 2-C, 3-F, 4-E</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Match&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">the following drugs with their ocular adverse effects?</span></span></span></span>(AIIMS MAY 2019)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-171440.png\" style=\"height:403px; width:1000px\" /></p>",
      "unique_key": "Q8709371",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390916,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans.&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">D. 1-D, 2-C, 3-F, 4-E</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The following are the drugs and their associated ocular adverse effects:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amiodarone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This drug is known to cause corneal deposits (cornea verticillata) and optic neuritis. The correct match for Amiodarone is D (Optic neuritis).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydroxychloroquine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This drug is associated with bull&rsquo;s eye maculopathy, a specific type of retinopathy. Therefore, Hydroxychloroquine is correctly matched with C (Retinopathy).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Systemic steroids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: When given topically, systemic steroids can cause open-angle glaucoma. However, when given systemically, they are known to cause posterior subcapsular cataract. Thus, systemic steroids are best matched with F (Cataract).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Digoxin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This drug can cause yellow vision, a condition where the patient perceives a yellow tint in their vision. Hence, Digoxin is correctly matched with E (Yellow vision).</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ocular adverse-effects of drugs:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Amiodarone:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Corneal deposits (cornea verticallata) <strong>Optic neuritis</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Hydroxychloroquine:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Bull&rsquo;s eye maculopathy (<strong>retinopathy</strong>).</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Systemic steroids:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Given topically &ndash; cause Open angle Glaucoma; Given systemically &ndash; cause Posterior subcapsular&nbsp;<strong>cataract</strong><strong>.</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><span style=\"color:#333333\"><strong>Digoxin:</strong>&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"><strong>Yellow vision</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: - KDT 8<sup>TH</sup>/880, 318, 560, Goodman Gilman 13<sup>th</sup>/&nbsp; 564</span></span></strong></span></span></p>",
      "correct_choice_id": 122781,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13986,
      "choices": [
        {
          "id": 55905,
          "text": "<p><span style=\"font-size:12.0pt;\">Colon</span></p>"
        },
        {
          "id": 55906,
          "text": "<p><span style=\"font-size:12.0pt;\">Breast</span></p>"
        },
        {
          "id": 55907,
          "text": "<p><span style=\"font-size:12.0pt;\">Prostate</span></p>"
        },
        {
          "id": 55908,
          "text": "<p><span style=\"font-size:12.0pt;\">Melanoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following given cancers rarely metastasize to the liver? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q1741733",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390917,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Prostate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Prostate Cancers rarely metastasize to the liver.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Prostate cancer tends to metastasize to bones via periprostatic venous plexus (Bateson) rather than the liver. Bone metastases are a hallmark of advanced prostate cancer.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A.</strong> <strong>Colon</strong>: Colon cancer commonly metastasizes to the liver. The liver is one of the most common sites of metastasis for colon cancer, and it frequently spreads to the liver through the bloodstream.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B.</strong> <strong>Breast</strong>: Breast cancer can metastasize to various organs, including the liver. Liver metastases in breast cancer are not uncommon, and the liver is considered a potential site of spread for breast cancer cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D.</strong> <strong>Melanoma</strong>: Melanoma is known for its propensity to metastasize to various organs, including the liver. Liver metastases are common in advanced melanoma cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common malignant tumors of the liver are metastasis. The liver is a common site of metastases from gastrointestinal tumors because of dissemination via the portal venous system. The most relevant such metastatic tumor of the liver to the surgeon is colorectal cancer because of the well-documented potential for long-term survival after its complete resection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The more frequent primary sites include carcinomas of the colon, pancreas, lung, and breast in adults, and neuroblastoma, Wilms tumor, and rhabdomyosarcoma in pediatric patients. Although the origin of the tumor is often known when metastases are biopsied, carcinomas of the pancreas, stomach, and lung are particularly notorious for being occult primary neoplasms.</span></p>",
      "correct_choice_id": 55907,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73663,
      "choices": [
        {
          "id": 293593,
          "text": "<p><span style=\"font-size:12.0pt;\">A only</span></p>"
        },
        {
          "id": 293594,
          "text": "<p><span style=\"font-size:12.0pt;\">A &amp; B</span></p>"
        },
        {
          "id": 293595,
          "text": "<p><span style=\"font-size:12.0pt;\">C &amp; D</span></p>"
        },
        {
          "id": 293596,
          "text": "<p><span style=\"font-size:12.0pt;\">A, B, C and D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is the best investigation for aneuploidy? (INICET NOV 2024)</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:16px;\">In Situ Hybridization</span></li><li><span style=\"font-size:16px;\">Conventional cytogenetics&nbsp;</span></li><li><span style=\"font-size:16px;\">PCR</span></li><li><span style=\"font-size:16px;\">Sanger sequencing</span></li></ol>",
      "unique_key": "Q3647655",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390918,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) A &amp; B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">For the detection of aneuploidy, <strong>both In Situ Hybridization (specifically FISH - Fluorescent In Situ Hybridization) and conventional cytogenetics&nbsp;</strong>are the best investigations. \"FISH technique is an important technique which not only helps to detect the presence of microdeletions or an excess number of certain types of genes being expressed it also helps to detect the presence of <strong>specific chromosomal translocations</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Conventional cytogenetics</strong>, though more time-consuming than FISH, is <strong>still an effective method for aneuploidy detection.</strong> It involves visualizing the chromosomes under a microscope during cell division to count them and look for gross abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Both techniques allow direct visualization of chromosomal material and can detect numerical abnormalities like aneuploidy. FISH is particularly valuable because it can rapidly detect common aneuploidies like <strong>trisomy 21, 18, 13 within 24-48 hours.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C &amp; D (PCR and Sanger sequencing):&nbsp;</strong>These techniques are not the best for detecting aneuploidy. PCR and Sanger sequencing are used for analyzing specific DNA sequences and mutations, but they cannot effectively detect changes in chromosome number.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>FISH (Fluorescent In Situ Hybridization) and conventional cytogenetics</strong> are the best techniques for detecting aneuploidy (abnormal chromosome numbers), while PCR and Sanger sequencing are used for specific sequence analysis but not aneuploidy detection.</span></p>",
      "correct_choice_id": 293594,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73663/INI-CET_Nov_2024_Pathology_Q_-_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73663/INI-CET_Nov_2024_Pathology_Q_-_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7074,
      "choices": [
        {
          "id": 28264,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">20.8 hours</span></span></span></p>"
        },
        {
          "id": 28265,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">6.9 hours</span></span></span></p>"
        },
        {
          "id": 28266,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">13.8 hours</span></span></span></p>"
        },
        {
          "id": 28267,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">9.8 hours</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The elimination rate constant of a drug is 0.05 hr. What is its half-life?&nbsp;</span></span>(INICET MAY 2021)</p>",
      "unique_key": "Q3101653",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390919,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. 13.8 hours</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Half-life is the time in which the plasma concentration of the drug becomes half.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The elimination rate constant of a drug reflects the fraction of drug that is removed from the body compartment per unit time.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The elimination rate constant = k = 0.05 hr.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Half-life = t1/2 = 0.693/k</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore t1/2 = 0.693/0.05 =13.8 hrs.</span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The half-life of a drug with an elimination rate constant of 0.05 hr is 13.8 hours, calculated using the formula t<sub>1/2</sub>=0.693/k</span></span></span></p>",
      "correct_choice_id": 28266,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13078,
      "choices": [
        {
          "id": 52274,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior staphyloma</span></p>"
        },
        {
          "id": 52275,
          "text": "<p><span style=\"font-size:12.0pt;\">Fundal coloboma</span></p>"
        },
        {
          "id": 52276,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital rubella</span></p>"
        },
        {
          "id": 52277,
          "text": "<p><span style=\"font-size:12.0pt;\">Toxoplasmosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In which of the following conditions do you see punched-out lesions of the retina? (</span>INICET May 2022)</p>",
      "unique_key": "Q3090688",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390920,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) Toxoplasmosis</strong></span></p><p><span style=\"font-size:10.5pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Toxoplasmosis is a parasitic infection caused by Toxoplasma gondii that affects the central nervous system and retina in humans.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It can occur as 3 forms:</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:12.0pt;\"><strong>Congenital</strong>: infants are typically born with inactive disease, and doctors may observe healed punched-out chorioretinal lesions in the macular region.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Acquired</strong>: can also result in similar punched-out lesions, along with punctate outer retinal toxoplasmosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Recurrent Toxoplasmosis:</strong> Patients may experience multiple episodes of retinal inflammation, leading to further accumulation of these punched-out lesions over time.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Posterior staphyloma:</strong> This refers to an outpouching or deformation of the posterior shell of the eye, often associated with severe myopia but not characterized by punched-out lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fundal coloboma:</strong> A congenital malformation resulting in missing pieces of tissue in structures forming the eye, such as the choroid and retina, which does not typically present as punched-out lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Congenital rubella:</strong> While it can cause retinal changes, the signature features often include salt and pepper retinopathy rather than punched-out lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The appearance of punched-out lesions in the retina is crucial for diagnosing toxoplasmosis. This understanding can aid in distinguishing toxoplasmosis from other infectious or congenital conditions that affect the retina, guiding appropriate diagnostic and therapeutic interventions.</span></p>",
      "correct_choice_id": 52277,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24687,
      "choices": [
        {
          "id": 98709,
          "text": "<p><span style=\"font-size:12.0pt;\">Treponema pallidum</span></p>"
        },
        {
          "id": 98710,
          "text": "<p><span style=\"font-size:12.0pt;\">CMV</span></p>"
        },
        {
          "id": 98711,
          "text": "<p><span style=\"font-size:12.0pt;\">Parvovirus B19</span></p>"
        },
        {
          "id": 98712,
          "text": "<p><span style=\"font-size:12.0pt;\">Toxoplasma gondii</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The transmission of infection during the perinatal period exhibits a range of symptoms, including anemia, potential myocarditis, high-output cardiac failure, and ascites. Identify the specific causative agent responsible for these manifestations:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(INICET MAY 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125642.jpg\" alt=\"\" width=\"400\" height=\"269\"></span></p>",
      "unique_key": "Q8983556",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390921,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Parvovirus B19</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The provided clinical scenario presents a patient with symptoms of anemia, myocarditis, high output cardiac failure, and ascites, along with an accompanying image displaying hydrops fetalis.</span></li><li><span style=\"font-size:12.0pt;\">These manifestations collectively suggest a diagnosis of erythema infectiosum, commonly known as Fifth disease, which is caused by parvovirus B19.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>MANIFESTATIONS OF PARVOVIRUS B19</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Fetus</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Severe anemia (transient aplastic crises)</span></li><li><span style=\"font-size:12.0pt;\">Pure red cell aplasia</span></li><li><span style=\"font-size:12.0pt;\">Congestive heart failure</span></li><li><span style=\"font-size:12.0pt;\">Hydrops fetalis</span></li><li><span style=\"font-size:12.0pt;\">Spontaneous abortion</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125642_U6cRlzs.jpg\" alt=\"\" width=\"400\" height=\"269\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Children/adults</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Fifth disease, erythema infectiosum, slapped cheek fever</span></li><li><span style=\"font-size:12.0pt;\">7−10-day incubation</span></li><li><span style=\"font-size:12.0pt;\">Nonspecific “flu-like” symptoms followed by raised, indurated facial rash (Slapped cheek)</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125639_pN7GMam.jpg\" alt=\"\" width=\"400\" height=\"338\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Adults</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Rash and arthralgias (involves wrist most often) are due to immune complexes in the skin and joints.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125640_sGdjSup.jpg\" alt=\"\" width=\"300\" height=\"195\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Treponema pallidum</strong> (Syphilis) in pregnancy leads to subsequent pregnancy loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. CMV (Cytomegalovirus)</strong> by trans placental spread causes fetal damage at all gestational ages. Features are periventricular calcifications, microcephaly, hearing loss, hydrops fetalis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Toxoplasma gondii</strong> intracerebral calcifications, hydrocephalus, chorioretinitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Parvovirus B19 is responsible for severe anemia, hydrops fetalis, and other serious complications in fetuses.</span></p>",
      "correct_choice_id": 98711,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13146,
      "choices": [
        {
          "id": 52545,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute congestive glaucoma</span></p>"
        },
        {
          "id": 52546,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute anterior uveitis</span></p>"
        },
        {
          "id": 52547,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignant glaucoma</span></p>"
        },
        {
          "id": 52548,
          "text": "<p><span style=\"font-size:12.0pt;\">Corneal ulcer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In which of the following is atropine contraindicated? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q4661918",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390922,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Acute congestive glaucoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The use of atropine is not recommended in cases of acute congestive or angle closure glaucoma due to the risk of increasing intraocular pressure.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Since atropine is a mydriatic, it may lead to the obstruction of the trabecular meshwork by the peripheral iris, causing a sudden increase in intraocular pressure.</span></li><li><span style=\"font-size:12.0pt;\">Dim light can also precipitate an attack.</span><ul><li><span style=\"font-size:12.0pt;\">Atropine may be indicated as a cycloplegic agent to alleviate pain and prevent synechiae formation in corneal ulcers and acute anterior uveitis.</span></li><li><span style=\"font-size:12.0pt;\">In malignant glaucoma, atropine can be the initial management option.</span></li><li><span style=\"font-size:12.0pt;\">In corneal ulcers, atropine is used as an adjuvant therapy, to reduce pain induced by ciliary muscle spasm via its cycloplegic effect.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Acute anterior uveitis</strong>: Atropine is actually beneficial in cases of acute anterior uveitis. It helps to relieve pain by paralyzing the ciliary muscle and preventing the formation of posterior synechiae (adhesions between the iris and the lens), which can complicate uveitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Malignant glaucoma</strong>: In malignant glaucoma, atropine might be used as part of the management strategy to try to break the attack by deepening the anterior chamber and pulling the lens-iris diaphragm backward.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Corneal ulcer</strong>: Atropine is used in the treatment of corneal ulcers to provide comfort by relieving the painful ciliary spasm and to prevent synechiae.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Atropine should be used cautiously, and is contraindicated in acute congestive glaucoma due to its potential to exacerbate the condition by further increasing intraocular pressure.</span></p>",
      "correct_choice_id": 52545,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13702,
      "choices": [
        {
          "id": 54769,
          "text": "<p><span style=\"color:#231f20;font-size:12.0pt;\">Head</span></p>"
        },
        {
          "id": 54770,
          "text": "<p><span style=\"color:#231f20;font-size:12.0pt;\">Neck</span></p>"
        },
        {
          "id": 54771,
          "text": "<p><span style=\"color:#231f20;font-size:12.0pt;\">Shaft</span></p>"
        },
        {
          "id": 54772,
          "text": "<p><span style=\"color:#231f20;font-size:12.0pt;\">Base</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which part of 2nd metatarsal is involved in the march fracture?(AIIMS MAY 2017)</span></p>",
      "unique_key": "Q8368918",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390923,
      "difficulty_level": "intermediate",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Neck</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>MARCH FRACTURE</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">March fracture is a <strong>stress fatigue fracture of second metatarsal neck &gt; 3rd metatarsal neck</strong>.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>second metatarsal is more prone</strong> to injury due to its <strong>limited motion from strong ligamentous attachment</strong> to the first and second cuneiforms and length compared to the other foot metatarsals.</span></li><li><span style=\"font-size:12.0pt;\">They result from a <strong>sudden increase in the intensity, duration, and frequency</strong> of activity without sufficient rest.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>repetitive impact</strong> on the metatarsals with weight-bearing exercises causes <strong>microfractures</strong>, which consolidate into stress fractures and are <strong>not the result of a single traumatic event</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-111207.JPG\" alt=\"\" width=\"200\" height=\"397\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Common Fracture Eponyms:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"color:#231f20;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_84.jpg\" alt=\"\" width=\"700\" height=\"918\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The march fracture involves the neck of the 2<sup>nd</sup> metatarsal followed by 3<sup>rd</sup> metatarsal.</span></li><li><span style=\"font-size:12.0pt;\">It is a stress fracture of the metatarsal.</span></li></ul>",
      "correct_choice_id": 54770,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6861,
      "choices": [
        {
          "id": 27412,
          "text": "<p><span style=\"font-size:12.0pt;\">4 times</span></p>"
        },
        {
          "id": 27413,
          "text": "<p><span style=\"font-size:12.0pt;\">32 times</span></p>"
        },
        {
          "id": 27414,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿8 times</span></p>"
        },
        {
          "id": 27415,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿16 times</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In the 2 vessels shown below, assume the pressure along both the vessels is the same and both follow linear flow pattern. What will be the amount of blood flow in A compared to B? (</span>AIIMS Nov 2017)</p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/aiims-physio-nov-2017-05.jpg\" alt=\"\" width=\"400\" height=\"129\"></span></p>",
      "unique_key": "Q9951713",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390924,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 8 times</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to Poiseuille's law:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/1202.jpg\" alt=\"\" width=\"300\" height=\"161\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">in which F is the rate of blood flow, ∆P is the pressure difference between the ends of the vessel, r is the radius of the vessel, l is length of the vessel, and h is viscosity of the blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Therefore, blood flow (F) inside the vessel is</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">﻿﻿Directly proportional to the pressure difference</span></li><li><span style=\"font-size:12.0pt;\">﻿﻿Inversely proportional to the viscosity:</span></li><li><span style=\"font-size:12.0pt;\">﻿﻿Directly proportional to the fourth power of radius</span></li><li><span style=\"font-size:12.0pt;\">﻿﻿Inversely proportional to length of the vessel</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">So, if the radius is doubled flow will increase by 2 to the power of 4 = 16</span></p><p><span style=\"font-size:12.0pt;\">And if the length of the vessel is also doubled, the reduces by half (÷2) = 8</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>According to Poiseuille's law blood flow (𝐹</strong><i><strong>F</strong></i><strong>) is:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Directly proportional to the pressure difference (Δ𝑃Δ<i>P</i>)</span></li><li><span style=\"font-size:12.0pt;\">Inversely proportional to the viscosity (𝜂<i>η</i>)</span></li><li><span style=\"font-size:12.0pt;\">Directly proportional to the fourth power of the radius (𝑟4<i>r</i>4)</span></li><li><span style=\"font-size:12.0pt;\">Inversely proportional to the length of the vessel (𝑙<i>l</i>)</span></li></ul>",
      "correct_choice_id": 27414,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6018,
      "choices": [
        {
          "id": 24042,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sensory level is from T10 to L1</span></span></span></p>"
        },
        {
          "id": 24043,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine contractility is mediated by innervations from level T7 - T8</span></span></span></p>"
        },
        {
          "id": 24044,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the 1st stage of labor, pain is due to the fibers at level of T10 - L1</span></span></span></p>"
        },
        {
          "id": 24045,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In early labor, pain is usually because of the uterine contraction</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is incorrect regarding innervation of the uterus?&nbsp;</span></span>(INICET MAY 2022)</p>",
      "unique_key": "Q8924184",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390925,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Uterine contractility is mediated by innervations from level T7 - T8</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The incorrect statement regarding the innervation of the uterus is option B. Uterine contractility is primarily mediated by hormonal mechanisms rather than by specific spinal innervations. Hormones such as estrogen, prostaglandins, and oxytocin play a significant role in inducing uterine contractions, while progesterone helps maintain uterine relaxation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Sensory level is from T10 to L1:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The sensory innervation of the uterus is indeed from spinal levels T10 to L1. These afferent fibers enter the spinal cord via the inferior hypogastric plexus and are responsible for transmitting sensory information from the uterus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. In the 1st stage of labor, pain is due to the fibers at level of T10 - L1:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> During the 1st stage of labor, pain is mediated by spinal segments T10 to L1. This pain is due to the distension of the cervix and lower uterine segment, as well as the contraction of the uterus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. In early labor, pain is usually because of the uterine contraction:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In early labor, pain is usually related to uterine contractions, which stimulate nociceptors in the genital tract and can cause discomfort and pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine contractility is not mediated by innervations from spinal level T7 - T8; instead, it is primarily influenced by hormonal mechanisms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/untitled-242.jpg\" style=\"height:223px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 500, DC Dutta&rsquo;s Textbook of Obstetrics, 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24043,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6639,
      "choices": [
        {
          "id": 26525,
          "text": "<p><span style=\"font-size:18px;\">Valproate</span></p>"
        },
        {
          "id": 26526,
          "text": "<p><span style=\"font-size:18px;\">Olanzapine</span></p>"
        },
        {
          "id": 26527,
          "text": "<p><span style=\"font-size:18px;\">Imipramine</span></p>"
        },
        {
          "id": 26528,
          "text": "<p><span style=\"font-size:18px;\">Venlafaxine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Abrupt stoppage of which of the following drugs causes agitation, anxiety and insomnia? (AIIMS May 2018)</span></p>",
      "unique_key": "Q8418248",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390926,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Venlafaxine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Abrupt discontinuation or dose reduction of venlafaxine has been known to result in a discontinuation syndrome characterized by agitation, anxiety, and insomnia. This is particularly noted with venlafaxine because of its short half-life. While all the drugs listed can have withdrawal symptoms if stopped suddenly, venlafaxine is particularly associated with these symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Valproate:</strong> Abrupt discontinuation can lead to seizure recurrence in those using it as an antiepileptic and can cause relapse of mood symptoms in those using it as mood stabilizer.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Olanzapine: </strong>Stopping it can result in a return of psychotic symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Imipramine:</strong> It can cause withdrawal symptoms, but they are typically more varied and might include headache, nausea, and malaise.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The key features of antidepressant discontinuation syndrome, often abbreviated as FINISH:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>F</strong>lu-like symptoms</span></li><li><span style=\"font-size:18px;\"><strong>I</strong>nsomnia</span></li><li><span style=\"font-size:18px;\"><strong>N</strong>ausea</span></li><li><span style=\"font-size:18px;\"><strong>I</strong>mbalance</span></li><li><span style=\"font-size:18px;\"><strong>S</strong>ensory disturbances (e.g., electric shock sensations)</span></li><li><span style=\"font-size:18px;\"><strong>H</strong>yperarousal (e.g., anxiety, agitation).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">It is particularly common with SSRIs and SNRIs with shorter half-lives, such as <strong>venlafaxine (most common)</strong>. Short acting SSRIs such as paroxetine and fluvoxamine are also commonly associated with discontinuation syndrome. Gradual tapering and patient education are essential to prevent and manage this syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Reference: Kaplan &amp; Sadock’s Comprehensive Textbook of Psychiatry, 10th edition, Page No 3150.</strong></span></p>",
      "correct_choice_id": 26528,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1222,
      "choices": [
        {
          "id": 4883,
          "text": "<p><span style=\"font-size:12.0pt;\">Contrast Dye study</span></p>"
        },
        {
          "id": 4884,
          "text": "<p><span style=\"font-size:12.0pt;\">X-ray</span></p>"
        },
        {
          "id": 4885,
          "text": "<p><span style=\"font-size:12.0pt;\">D Angiography</span></p>"
        },
        {
          "id": 4886,
          "text": "<p><span style=\"font-size:12.0pt;\">CT scan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During rounds, your senior was discussing the given image. The following is an image of which of the following investigations? (INICET MAY 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-140.jpg\" alt=\"\" width=\"475\" height=\"350\"></span></p>",
      "unique_key": "Q7824952",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390927,
      "difficulty_level": "intermediate",
      "subjects_id": [
        17
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. CT scan</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The above given image is a CT scan image since the bone can be identified as a high-density structure which appears white.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CT scan is an imaging modality which uses X-rays for cross sectional images of the body and the density of the tissue through which this x-ray beam passes is measured from the calculation of attenuation coefficient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Contrast Dye study:</strong> While contrast may be used in CT scans, the term \"contrast dye study\" alone does not specifically indicate a CT scan.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. X-ray:</strong> Typically provides two-dimensional imaging and lacks the cross-sectional detail shown in these images.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. D Angiography:</strong> Focuses on blood vessels using contrast material and typically does not provide detailed images of other anatomical structures as seen in these scans.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CT scans are invaluable in medical imaging for providing detailed cross-sectional views of internal structures, utilizing X-ray technology to distinguish between different tissue densities, evident from the white appearance of bone and detailed soft tissue visualization in the images.</span></p>",
      "correct_choice_id": 4886,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4304,
      "choices": [
        {
          "id": 17193,
          "text": "<p><span style=\"font-size:12.0pt;\">Bezold abscess</span></p>"
        },
        {
          "id": 17194,
          "text": "<p><span style=\"font-size:12.0pt;\">Griesinger's sign</span></p>"
        },
        {
          "id": 17195,
          "text": "<p><span style=\"font-size:12.0pt;\">Battle's sign</span></p>"
        },
        {
          "id": 17196,
          "text": "<p><span style=\"font-size:12.0pt;\">Delta sign</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is absent in a case of otitis media among the options provided? (</span>INICET Nov 2020)</p>",
      "unique_key": "Q9949895",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390928,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Battle's sign</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Battle's sign, characterized by ecchymosis (bruising) over the mastoid process, is typically indicative of a basilar skull fracture, specifically fractures involving the temporal bone. It is not associated with otitis media, which is an infection or inflammation of the middle ear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture34.jpg\" alt=\"\" width=\"300\" height=\"310\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Bezold abscess</strong>: This abscess is a serious complication of otitis media. It occurs when the infection spreads from the mastoid process into the surrounding tissues, leading to a collection of pus.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_U12kS2b.png\" width=\"368\" height=\"436\"></p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Griesinger's sign:</strong> This sign is associated with lateral sinus thrombosis, a rare but severe complication of otitis media and mastoiditis. It involves tenderness and swelling behind the ear and along the mastoid bone.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_VzbRqdT.png\" width=\"268\" height=\"281\"></p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D. Delta sign:</strong> Also related to lateral sinus thrombosis, the Delta sign typically appears on contrast-enhanced imaging studies as a NON enhancement at thrombosed area of sinus, a complication arising from otitis media.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_E3iSA6N.png\" width=\"294\" height=\"281\"></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While otitis media can lead to various complications, including Bezold abscess and lateral sinus thrombosis (indicated by Griesinger’s sign and Delta sign), Battle's sign is not associated with this condition. Instead, Battle's sign should prompt an evaluation for temporal bone fractures, emphasizing the importance of distinguishing between signs of infection and trauma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 87, 93, 507</strong></span></p>",
      "correct_choice_id": 17195,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6681,
      "choices": [
        {
          "id": 26693,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypnogram</span></p>"
        },
        {
          "id": 26694,
          "text": "<p><span style=\"font-size:12.0pt;\">Electroencephalogram</span></p>"
        },
        {
          "id": 26695,
          "text": "<p><span style=\"font-size:12.0pt;\">Polysomnogram</span></p>"
        },
        {
          "id": 26696,
          "text": "<p><span style=\"font-size:12.0pt;\">Epworth sleep assessment</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What does the given image represent?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/11/hypnogram-of-sleep-cycle-in-a-healthy-young-adult-normal-sleep-involves-cycling.png\" alt=\"\" width=\"400\" height=\"255\"></p>",
      "unique_key": "Q7693617",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390929,
      "difficulty_level": "difficult",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Hypnogram</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Image is showing a graphical representation of the stages of sleep over time, which is seen in Hypnogram.</span></p><p><span style=\"font-size:10.5pt;\">&nbsp;</span></p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Electroencephalogram (EEG):</strong> A graphical representation of electrical activity in the brain. The tracing typically displays waveforms such as alpha, beta, delta, and theta waves.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Polysomnogram: </strong>A comprehensive recording used during a sleep study that includes an EEG (brain activity), as well as eye movements, muscle activity, heart rate, respiratory effort, air flow, and blood oxygen levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Epworth Sleep Assessment:</strong> It's not a graph or image; it's a questionnaire used to determine the level of daytime sleepiness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypnogram</span><span style=\"color:#374151;font-size:12.0pt;\"> is a graphical representation of the stages of sleep over time, usually throughout a night.</span></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Reference: Textbook of Psychiatry by Allan Tasman, 4th edition, Page No 1271.</strong></span></p>",
      "correct_choice_id": 26693,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60459,
      "choices": [
        {
          "id": 241129,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amlodipine</span></span></p>"
        },
        {
          "id": 241130,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoprolol</span></span></p>"
        },
        {
          "id": 241131,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Losartan</span></span></p>"
        },
        {
          "id": 241132,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Furosemide</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A hypertensive patient on medication presents with the following lab values:</span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">K⁺: 6.5 meq/L</span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Na⁺: 137 meq/L</span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urea: 42 mg/dL</span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Creatinine: 3.8 mg/dL</span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs should be stopped?</span><span style=\"background-color:lime\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></p>",
      "unique_key": "Q5287511",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390930,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Losartan</strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In this hypertensive patient with hyperkalemia, <strong>losartan</strong> must be stopped.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Losartan is a competitive <strong>angiotensin II (AT1) receptor antagonist</strong>, which binds to the AT1 receptor with high affinity. Uses of losartan include:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Antihypertensive</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Renoprotective drug in diabetes mellitus</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Stroke prophylaxis</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Portal hypertension in cirrhosis without compromising renal function</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Anti-aggregant as it is a competitive antagonist of the thromboxane A2 receptor.</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Hyperkalemia</strong> is an important side effect of ARBs. Losartan appears to be a safe and efficacious agent to lower serum uric acid levels in patients with hyperuricemia.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Amlodipine</strong>:<strong> </strong>Gingival hyperplasia and ankle swelling are side effects of calcium channel blockers like amlodipine. Ankle edema occurs due to increased hydrostatic pressure in the capillaries present in the dependent parts of the body. This is due to reflex constriction of postcapillary vessels. Other common side effects of amlodipine include headache, dizziness, and abdominal pain.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Metoprolol</strong>:<strong> </strong>Metoprolol is a cardioselective beta-blocker. Cardioselective beta-blockers are <strong>less likely to cause hyperkalemia</strong> as an adverse effect. The risk of metoprolol-induced hyperkalemia is increased if the patient is also diabetic.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Furosemide</strong>:<strong> </strong>Furosemide is a <strong>loop diuretic</strong>. It acts by inhibiting the Na⁺-K⁺-2Cl⁻ symporter in the thick ascending limb of the loop of Henle, resulting in increased excretion of sodium, potassium, and chloride. <strong>Hypokalemia</strong>, hyperuricemia, hypocalcemia, and hypomagnesemia are the important side effects.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Losartan, an ARB (angiotensin receptor blocker), should be discontinued in hypertensive patients with hyperkalemia as it can worsen potassium retention.</span></span></p>",
      "correct_choice_id": 241131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6725,
      "choices": [
        {
          "id": 26869,
          "text": "<p><span style=\"font-size:12.0pt;\">Difference in alveolar pressure during inspiration and expiration</span></p>"
        },
        {
          "id": 26870,
          "text": "<p><span style=\"font-size:16px;\">Difference in concentration&nbsp;of surfactant during inspiration and expiration</span></p>"
        },
        {
          "id": 26871,
          "text": "<p><span style=\"font-size:12.0pt;\">Difference in airway resistance during inspiration and expiration</span></p>"
        },
        {
          "id": 26872,
          "text": "<p><span style=\"font-size:12.0pt;\">Inspiration is active and expiration is passive</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Difference in trajectory between inspiratory loop and the expiratory loop in the curve is due to: (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-174628.png\" alt=\"\" width=\"400\" height=\"352\"></span></p>",
      "unique_key": "Q9066115",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390931,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><strong>Ans. B) Difference in concentration of surfactant during inspiration and expiration</strong></p><p>&nbsp;</p><p>The above shows the compliance diagram of lung</p><p>&nbsp;</p><p>Compliance Diagram of the Lungs</p><p>&nbsp;</p><p>It is a diagram relating lung volume changes to changes in transpulmonary pressure.&nbsp;</p><p>&nbsp;</p><p><strong>The characteristics of the compliance diagram are determined</strong></p><p>&nbsp;</p><p>The surfactant, secreted by type II pneumocytes, reduces surface tension in alveoli.</p><p><br>During inspiration, alveoli expand, decreasing the surfactant concentration, which leads to increased surface tension, requiring more pressure to keep alveoli open.</p><p><br>During expiration, alveoli deflate, increasing surfactant concentration, thus decreasing surface tension, and requiring less pressure.</p><p><br>This asymmetry in surface tension during inspiration and expiration contributes to the difference in the trajectory (hysteresis) of the curve<br>&nbsp;</p><p>The tissue elastic forces tending to cause collapse of the air-filled lung represent only about one third of the total lung elasticity, whereas the fluid-air surface tension forces in the alveoli represent about two thirds.</p><p>&nbsp;</p><p>Thus, a greater transpulmonary pressure is required to open a previously closed airway due to surface tension at the air-water interface due to surfactant deficit, than to keep an open airway from closing, reflecting abundant surfactant.</p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KaAUiVc.png\" width=\"372\" height=\"207\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Surfactant concentration increases during expiration (smaller alveoli → surfactant molecules closer), lowering surface tension and making expiration easier compared to inspiration. This is the correct cause of hysteresis</strong></p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Difference in alveolar pressure during inspiration and expiration:</strong> Incorrect, as this refers to the pressure gradients that drive airflow but does not directly cause the loop shape differences seen in the compliance graph.</p><p>&nbsp;</p><p><strong>Option C.</strong>&nbsp;Airway resistance <strong>can be higher during expiration </strong>due to dynamic airway compression, especially in obstructive diseases.</p><p>However, the P-V loop is a static curve, plotted during slow, controlled breathing or when airflow has ceased — not during forced maneuvers — so airway resistance has minimal impact on this loop. This might be more relevant to flow-volume loops, not pressure-volume loops</p><p>&nbsp;</p><p><strong>Option D.</strong> This is true physiologically — inspiration involves active muscle contraction, and expiration is usually passive at rest. But this does not explain the hysteresis in the pressure-volume loop. &nbsp;The loop reflects lung compliance and surface tension, not the energy used for breathing.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>The difference between inspiratory and expiratory pressure-volume loops (hysteresis) is primarily due to dynamic changes in surfactant concentration, which alters surface tension between inspiration and expiration. Understanding this helps explain lung compliance behavior and the role of surfactant in stabilizing alveoli.</p>",
      "correct_choice_id": 26870,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13724,
      "choices": [
        {
          "id": 54857,
          "text": "<p style=\"margin-left:-5px;\"><span style=\"font-size:12.0pt;\">It is the main restraint in posterior drawer test</span></p>"
        },
        {
          "id": 54858,
          "text": "<p style=\"margin-left:-5px;\"><span style=\"font-size:12.0pt;\">It is an extrasynovial structure</span></p>"
        },
        {
          "id": 54859,
          "text": "<p style=\"margin-left:-5px;\"><span style=\"font-size:12.0pt;\">It is the main restraint to internal rotation</span></p>"
        },
        {
          "id": 54860,
          "text": "<p style=\"margin-left:-5px;\"><span style=\"font-size:12.0pt;\">It originates from anterolateral aspect of medial femoral condyle in the area of intercondylar notch</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is incorrect about PCL? (</span>AIIMS Nov 2017)</p>",
      "unique_key": "Q9803392",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390932,
      "difficulty_level": "intermediate",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. It is the main restraint to internal rotation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>LIGAMENT INJURIES OF THE KNEE JOINT</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/ACL_dEPDfQy.jpg\" width=\"1654\" height=\"2045\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">PCL is the an extrasynovial structure originating from the anterolateral aspect of the medial femoral condyle in the area of intercondylar notch.</span></li><li><span style=\"font-size:12.0pt;\">It is the main restraint to the posterior translation of the knee i.e., the backward gliding of the tibia over the femur.</span></li><li><span style=\"font-size:12.0pt;\">While evaluating the patient during physical examination, PCL is the main restraint in the posterior drawer test.</span></li></ul>",
      "correct_choice_id": 54859,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11133,
      "choices": [
        {
          "id": 44498,
          "text": "<p><span style=\"font-size:18px;\">Call the infection control team of the hospital</span></p>"
        },
        {
          "id": 44499,
          "text": "<p><span style=\"font-size:18px;\">Mop it</span></p>"
        },
        {
          "id": 44500,
          "text": "<p><span style=\"font-size:18px;\">Cover it with 1% sodium hypochlorite</span></p>"
        },
        {
          "id": 44501,
          "text": "<p><span style=\"font-size:18px;\">Clean with absorbable material</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>You're an intern in a bustling hospital laboratory. As you're overseeing the day's activities, you notice that a newly appointed technician accidentally spills a blood sample on the floor. The technician, looking panicked, turns to you for guidance. Given the potential risks associated with blood spills, what is the most immediate and appropriate action you should instruct the technician to take? </strong><i><strong>[AIIMS NOV 2018]</strong></i></span></p>",
      "unique_key": "Q5121548",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390933,
      "difficulty_level": "difficult",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Clean with absorbable material</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">In this situation, the next crucial action to take is to utilize absorbent material for cleaning up the spilled blood. Once the cleaning is complete, the used absorbent material should be disposed of in the designated yellow bin. Subsequently, a sodium hypochlorite solution is employed to thoroughly decontaminate the affected surface. The specific concentrations of sodium hypochlorite employed are as follows:</span><ul><li><span style=\"font-size:18px;\">&lt; 10 mL blood spill - 1:100 dilution to decontaminate non-porous surfaces</span></li><li><span style=\"font-size:18px;\">&gt;10 mL blood spill or culture spill - 1:10 dilution for the first application, followed by 1:100 dilution</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Call the infection control team of the hospital:</strong> While important, this is not the immediate action to take to contain the spill.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Mop it:</strong> Mopping without proper absorbent material and decontamination procedures could spread the contamination.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Cover it with 1% sodium hypochlorite:</strong> This step should follow the initial clean-up with absorbent material to ensure thorough decontamination.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Hypochlorites in Hospital waste Management</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Disinfection of countertops and floors</span></li><li><span style=\"font-size:18px;\">Decontamination of blood spills</span></li><li><span style=\"font-size:18px;\">Irrigating agent in endodontic treatment</span></li><li><span style=\"font-size:18px;\">Disinfectant for manikins, laundry, dental appliances, hydrotherapy tanks</span></li><li><span style=\"font-size:18px;\">Treatment of liquid medical waste before disposal</span></li><li><span style=\"font-size:18px;\">Decontaminating water distribution systems in dialysis</span></li></ul>",
      "correct_choice_id": 44501,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1001,
      "choices": [
        {
          "id": 4000,
          "text": "<p><span style=\"font-size:12pt;\">2 min</span></p>"
        },
        {
          "id": 4001,
          "text": "<p><span style=\"font-size:12pt;\">5 min</span></p>"
        },
        {
          "id": 4002,
          "text": "<p><span style=\"font-size:12pt;\">40 min</span></p>"
        },
        {
          "id": 4003,
          "text": "<p><span style=\"font-size:12pt;\">20 min</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Duration of action of Proparacaine? (</span>AIIMS May 2019)</p>",
      "unique_key": "Q9499874",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390934,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) 20 mins</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Proparacaine:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Duration of Action:</strong> The duration of action of proparacaine is approximately 15-20 minutes.</span></li><li><span style=\"font-size:12pt;\"><strong>Uses:</strong> Proparacaine hydrochloride is used as a topical anesthetic agent, especially for ophthalmic surgeries such as:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Tonometry</span></li><li><span style=\"font-size:12pt;\">Gonioscopy</span></li><li><span style=\"font-size:12pt;\">Removal of corneal foreign bodies</span></li><li><span style=\"font-size:12pt;\">Short corneal and conjunctival procedures</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The duration of action of proparacaine is approximately 15-20 minutes, making it suitable for short ophthalmic procedures.</span></li></ul>",
      "correct_choice_id": 4003,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3678,
      "choices": [
        {
          "id": 14691,
          "text": "<p><span style=\"font-size:12.0pt;\">Buffy coat is used to diagnose the parasite</span></p>"
        },
        {
          "id": 14692,
          "text": "<p><span style=\"font-size:12.0pt;\">It is an obligate extracellular parasite</span></p>"
        },
        {
          "id": 14693,
          "text": "<p><span style=\"font-size:12.0pt;\">It is transmitted from sheep</span></p>"
        },
        {
          "id": 14694,
          "text": "<p><span style=\"font-size:12.0pt;\">Stibogluconate is the first line of treatment in India</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Bone marrow aspirate of a patient shows the following features. Which of the following is true?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET</span> <span style=\"font-size:12.0pt;\">NOV 2018)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-274.jpg\" alt=\"\" width=\"442\" height=\"351\"></span></p>",
      "unique_key": "Q3888825",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390935,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Buffy coat is used to diagnose the parasite</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image shows the amastigote form of leishmaniasis located intracellularly in macrophages. Buffy coat is used to diagnose the parasite.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Buffy coat is the portion of blood that contains concentrates of white blood cells, including monocytes and platelets, and for obvious reasons its smear can be examined for detection of L. donovani bodies in suspected VL patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Detection of Leishmania donovani bodies in peripheral blood buffy coat smears is an alternative and minimally invasive procedure for the parasitological diagnosis of VL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PCR assay with buffy coat preparations to detect Leishmania DNA has been found to be 10 times more sensitive than that with whole-blood preparation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Serodiagnosis is a valid and the detection in serum and urine specimens of antileishmanial <strong>antibody against recombinant antigens such as rK39 by rapid immunochromatographic tests</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Aldehyde test of Napier: Widely used for surveillance</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Serological tests for diagnosis: Rapid dipstick test, Direct agglutination test, ELISA, Indirect Fluorescent Antibody Test</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Leishmanin (<strong>Montenegro</strong>) test: Induration of <strong>5mm or more</strong> is considered positive, usually positive 4-6 weeks after onset in cutaneous leishmaniasis, valuable for distinguishing immune from nonimmune subjects and endemicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It is an obligate extracellular parasite:</strong> This is incorrect. Leishmania donovani is an intracellular parasite that resides within macrophages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. It is transmitted from sheep:</strong> This is incorrect. Leishmania is transmitted by the bite of infected female phlebotomine sandflies, not by sheep.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Stibogluconate is the first line of treatment in India:</strong> This is partially outdated. Sodium stibogluconate was once the first line of treatment, but now liposomal amphotericin B and miltefosine are commonly used as first-line treatments in India due to increased resistance to antimonials.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Buffy coat is used to diagnose Leishmania donovani by detecting the amastigote form in intracellular macrophages in patients with visceral leishmaniasis.</span></p>",
      "correct_choice_id": 14691,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11083,
      "choices": [
        {
          "id": 44298,
          "text": "<p><span style=\"font-size:18px;\">Maternal Deaths per 10,000 live births&nbsp;</span></p>"
        },
        {
          "id": 44299,
          "text": "<p><span style=\"font-size:18px;\">Maternal Deaths per 100,000 live births&nbsp;</span></p>"
        },
        {
          "id": 44300,
          "text": "<p><span style=\"font-size:18px;\">Maternal Deaths per 10,000 women in reproductive age group&nbsp;</span></p>"
        },
        {
          "id": 44301,
          "text": "<p><span style=\"font-size:18px;\">Maternal Deaths per 100,000 women in reproductive age group</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Dr. Aishwarya, a public health official, is discussing the maternal health situation in a rural district of Uttar Pradesh at a Panchayat meeting. She emphasizes the importance of understanding the maternal mortality ratio (MMR) for her district. Which definition best describes the MMR? </strong><i><strong>[AIIMS MAY 2020]</strong></i></span></p>",
      "unique_key": "Q8123506",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390936,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Maternal Deaths per 100,000 live births&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">MMR is Maternal deaths expressed as per 100,000 live births.</span></li><li><span style=\"font-size:18px;\">Maternal Mortality rate (MMR): Maternal deaths expressed as per 100,000 live births, where a ‘maternal death’ is defined as ‘death of a woman while pregnant or during delivery or within 42 days (6 weeks) of termination of pregnancy, irrespective of duration or site of pregnancy, from any cause related to or aggravated by the pregnancy or its management but not from accidental or incidental causes’.</span></li><li><span style=\"font-size:18px;\">MMR is a ratio (Maternal mortality rate is a misnomer; MMR is not a rate)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-144548.png\" alt=\"\" width=\"500\" height=\"55\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>MMR World: 216 per 100,000 live births; Causes of MMR (globally):</strong></span><ul><li><span style=\"font-size:18px;\">Hemorrhage (25%)</span></li><li><span style=\"font-size:18px;\">Indirect causes (20%)</span></li><li><span style=\"font-size:18px;\">Infection (15%)</span></li><li><span style=\"font-size:18px;\">Unsafe abortion (13%)</span></li><li><span style=\"font-size:18px;\">Eclampsia (12%)</span></li><li><span style=\"font-size:18px;\">Obstructed labour (8%)</span></li></ul></li><li><span style=\"font-size:18px;\"><strong>MMR India: 97 per 100,000 live births [2023]; Causes of MMR (India) [SRS 2023]:</strong></span><ul><li><span style=\"font-size:18px;\"><strong>Hemorrhage (38%)</strong></span></li><li><span style=\"font-size:18px;\">Other conditions (34%)</span></li><li><span style=\"font-size:18px;\">Sepsis (11%)</span></li><li><span style=\"font-size:18px;\">Abortion (8%)</span></li><li><span style=\"font-size:18px;\">Obstructed labour (5%)</span></li><li><span style=\"font-size:18px;\">Hypertensive disorders (5%)</span></li></ul></li><li><span style=\"font-size:18px;\"><strong>Maternal mortality rate (MMRate):</strong> Dividing the average annual number of maternal deaths in a population by the average number of women of reproductive age (typically those aged 15 to 49 years) who are alive during the observation period.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">MMRate reflects not only the risk of maternal death per pregnancy or per birth, but also the level of fertility in a population</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">MMR is a crucial indicator of maternal health in a population, reflecting the risk of maternal death associated with childbirth and its management.</span></li><li><span style=\"font-size:18px;\">It is typically expressed per 100,000 live births to provide a clear picture of maternal health risks and the effectiveness of health interventions aimed at reducing these risks in specific areas or populations.</span></li></ul>",
      "correct_choice_id": 44299,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5804,
      "choices": [
        {
          "id": 23187,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic tubal ligation</span></span></span></p>"
        },
        {
          "id": 23188,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Copper-T</span></span></span></p>"
        },
        {
          "id": 23189,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Implanon</span></span></span></p>"
        },
        {
          "id": 23190,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LNG-IUD</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is an irreversible method of contraception?&nbsp;</span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q9951383",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390937,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Laparoscopic tubal ligation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contraceptive methods can be classified into temporary (reversible) and permanent (irreversible) methods.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Permanent Methods (Irreversible):</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic Tubal Ligation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a surgical procedure where the fallopian tubes are cut, tied, or sealed to prevent pregnancy permanently. It is considered an irreversible method of contraception as it is intended to be a permanent solution for women who do not wish to have more children.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Temporary Methods (Reversible):</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Copper-T (Intrauterine Device - IUD):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A long-term but reversible method that can be removed when pregnancy is desired.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Implanon (Subdermal Contraceptive Implant):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A long-term reversible method that can be removed to restore fertility.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LNG-IUD (Levonorgestrel Intrauterine Device):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Another long-term reversible method that can be removed when pregnancy is desired.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic tubal ligation is a permanent (irreversible) method of contraception.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 611, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23187,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14000,
      "choices": [
        {
          "id": 55961,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">27%</span></span></span></span></p>"
        },
        {
          "id": 55962,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">36%</span></span></span></span></p>"
        },
        {
          "id": 55963,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">45%</span></span></span></span></p>"
        },
        {
          "id": 55964,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">18%</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 22-year-old woman presented with burns injury. She is covered with burns on her head and neck, both upper limbs, front and back of the chest. Calculate the percentage of burns? (AIIMS MAY 2020)</span></span></p>",
      "unique_key": "Q6042555",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390938,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 45%</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To calculate the percentage of burns, the &quot;<strong>Rule of Nines</strong>&quot; is commonly used in medicine. According to this rule, each area of the body is assigned a percentage value. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For example, the <strong>head and neck</strong> are typically assigned <strong>9%,</strong> each <strong>upper limb is assigned 9% (18%</strong> <strong>total for both),</strong> and the <strong>front and back</strong> of the <strong>chest are assigned 18%.</strong> When we <strong>add these percentages together,</strong> we get a <strong>total of 45% burns.</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:&nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The percentage of burns calculated in the given patient is 45% according to Wallace&#39;s rule of nine.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calculation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burns on the head &amp; neck would account for 9% of burns.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burns on both upper limbs (9% for each limb) would add to 18%</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burns on both sides of the chest would account for 18%</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therefore, the total percentage of burns in the given patient is 9+18+18 = 45%</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wallace&#39;s rule of nine:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-90_poZazyg.jpg\" style=\"height:529px; width:484px\" /></span></strong></span></span></p>",
      "correct_choice_id": 55963,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 468,
      "choices": [
        {
          "id": 1868,
          "text": "<p>1</p>"
        },
        {
          "id": 1869,
          "text": "<p>10</p>"
        },
        {
          "id": 1870,
          "text": "<p>12</p>"
        },
        {
          "id": 1871,
          "text": "<p>13</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young patient presented with hypoparathyroidism, absent thymus and tetany. Which of the following marked areas in the picture is defective in this condition?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-21.jpg\" alt=\"\" width=\"300\" height=\"294\"></span></p>",
      "unique_key": "Q3323952",
      "question_audio": null,
      "question_video": null,
      "map_id": 35390939,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. 12</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical scenario of hypoparathyroidism, absent thymus, and tetany is suggestive of DiGeorge syndrome. It is caused by defective development of the third and fourth pharyngeal pouch.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the image of pharyngeal pouches, \"12\" points to the thymus (derivative of 3rd pharyngeal pouch). Since in the above question, the thymus is absent, option 3 will be the most appropriate answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-22.jpg\" alt=\"\" width=\"700\" height=\"371\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. (1): </strong>1st Pharyngeal pouches, which is unrelated to the thymus or parathyroid glands directly involved in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. (10):</strong> External auditory meatus, which is not implicated in DiGeorge syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. (13):</strong> Superior parathyroid gland, derived from the fourth pharyngeal pouch. Although it's closely related to the condition described, the primary indicator in this scenario, given the patient's symptoms, is the thymus rather than the parathyroid glands.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">DiGeorge syndrome, also known as 22q11.2 deletion syndrome, is a genetic disorder caused by a missing piece of chromosome 22. It is characterized by a wide range of symptoms that can vary in severity, but are typically grouped together as mnemonic CATCH -22</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mnemonic \"CATCH-22\":</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">C - Cardiac abnormalities, such as ventricular septal defects (VSD) and tetralogy of Fallot.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A - Abnormal facies, including a small chin, low-set ears, and wide-set eyes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">T - Thymic aplasia or hypoplasia, leading to a weakened immune system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">C - Cleft palate or other palate abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">H - Hypocalcemia or low levels of calcium due to underdeveloped or missing parathyroid glands.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">22 - Refers to the chromosome 22q11.2 deletion, which causes the syndrome.</span></p>",
      "correct_choice_id": 1870,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}